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SOMMARIO
 
Il biofilm batterico è una comunità strutturata di cellule racchiuse in una matrice 
polimerica autoprodotta, composta principalmente da esopolisaccaridi, acidi 
nucleici, lipopolisaccaridi e proteine (Costerton, 1999) capace di proteggere i 
batteri dai meccanismi di difesa dell’ospite e dagli antibiotici favorendo la 
persistenza dell’infezione. Inoltre la vicinanza tra le cellule batteriche all’interno 
della comunità favorisce lo scambio “orizzontale” di materiale genetico compresi 
i geni dell’antibiotico resistenza (Flemming, 2007). In campo medico le infezioni 
biofilm-correlate possono portare al diffondersi di infezioni persistenti e difficili 
da eradicare (Bjarnsholt, 2013).  
Recenti sviluppi nel campo delle nanotecnologie hanno suggerito come 
nanoparticelle (NPs) di origine biogenica, potrebbero essere d’aiuto nel 
trattamento di infezioni biofilm-correlate (Kostakioti; 2013). 
Obiettivo di questa tesi di dottorato è stato analizzare l’ azione antibatterica e 
antibiofilm di nanoparticelle di selenio (SeNPs) bio-sintetizzate da due ceppi 
batterici di origine ambientale (Bacillus Mycoides SeITE01 e Stenotrophomonas 
malthopilia SeITE02). Le SeNPs sono state caratterizzate per le loro proprietà 
chimico-fisiche, la loro attività antibatterica e antibiofilm e confrontate con NPs di 
selenio prodotte chimicamente. L’attività antibatterica e antibiofilm dei tre tipi di 
SeNPs è stata valutata nei confronti di una serie di isolati clinici e ceppi di 
riferimento di Pseudomonas aeruginosa. Le NPs prodotte da S. maltophilia (Sm-
SeNPs(-)) si sono dimostrate le più attive con valori di MIC, molto bassi per 
alcuni dei ceppi testati, e una rilevante attività inibente la formazione e 
disgregante il biofilm.  
SeNPs con caratteristiche simili ma diversa origine hanno mostrato una diversa 
attività antibatterica. Questo, unitamente al diverso meccanismo di bio-sintesi, 
induce ad ipotizzare che la superficie delle NPs sia ricoperta da diverse 
biomolecole (coating), importanti per la loro attività e interazione con le cellule 
batteriche. 
Abbiamo poi indagato il ruolo del coating nell’azione delle NPs sottoponendo le 
Sm-SeNPs(-) a diversi trattamenti denaturanti (10%SDS, 10%SDS+10’bollitura, 
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10%SDS+30’bollitura) e confrontando l’ attività antibatterica ed antibiofilm delle 
NPs ottenute con SeNPs non trattate. L’attività antibatterica diminuiva 
progressivamente alla perdita del coating superficiale, mostrando un progressivo 
aumento del valore di MIC in corrispondenza del’impoverimento, nella 
percentuale di proteine e carboidrati. L’attività antibiofilm (effetto sulla biomassa, 
sulla vitalità cellulare e microscopia a fluorescenza) ha confermato l’azione 
antibatterica mostrata in precedenza. In accordo con i dati presenti in letteratura 
(Tran, 2009) abbiamo poi evidenziato come il trattamento con Sm-SeNPs(-) 
induca produzione di ROS. 
Successivamente si è valutata la possibile attività antibatterica sinergica tra SeNPs 
e alcuni antibiotici. La combinazione di NPs e antibatterici non ha portato ad un 
incremento rilevante dell’attività antibiofilm, avendo le SeNPs di per sé una 
sostanziale azione. Solo in un caso (un isolato clinico multi-resistente), 
l’abbinamento di Sm-SeNPs(-) e antibiotici ha mostrato sinergismo. 
Infine, l’attività antibiofilm delle Sm-SeNPs(-) è stata saggiata in una serie di 
modelli complessi in vitro (ferita cronica e flow cells) e in vivo (Caenorhabditis 
elegans e modello murino). Il modello di ferita è un derma artificiale formato da 
diversi strati di collagene, che ricrea le condizioni di ferite croniche e da ustione. 
In questo caso le NPs non hanno mostrato una buona attività contro i biofilm di P. 
aeruginosa e S. aureus testati.  
Nelle flow cells vengono ricreate le condizioni di un flusso costante di nutrienti 
che si possono ritrovare in situazioni reali come cateteri vescicali o venosi. L’ 
attività delle NPs è stata valutata monitorando la riduzione delle cellule vitali 
presenti nel biofilm durante il trattamento con un flusso costante di 128µg/ml di 
Sm-SeNPs(-), e al termine di quest’ultimo. 
Nel nematode C. elegans le SeNPs hanno mostrando una tossicità dipendente 
dalla concentrazione, mentre nel più complesso modello di topo (wild type e 
affetto da Fibrosi Cistica), l’instillazione tracheale di NPs non ha dato tossicità 
sistemica. In ultimo, sono state utilizzate linee cellulari umane (cellule dendritiche 
e fibroblasti).  
Complessivamente i dati raccolti al termine di questa tesi di dottorato evidenziano 
come nanoparticelle di selenio bio-sintetizzate da batteri possano costituire in 
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vitro una valida alternativa all’utilizzo della convenzionale terapia antibatterica ed 
in alcuni casi siano addirittura più efficaci. Inoltre non si sono dimostrate tossiche 
nel modello murino né in linee cellulari umane.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 
 
ABSTRACT
 
Bacterial biofilms are microbial communities embedded in a highly hydrated 
exopolymer (EPS) matrix and can exist on different biotic and abiotic surfaces. 
The presence of these protective EPS matrix allows biofilms to survive in harsh 
environmental conditions and to resist to antiobiotic action, representing a 
challenge for the common antimicrobial therapy. Recently, a wide range of 
nanoparticles (i.e. silver, gold, iron oxide) have been intensively studied as 
antimicrobial agents including their use against multidrug-resistant (MDR) 
bacteria. 
We evaluated the physicochemical characteristics and biological activity of 
biogenic selenium nanoparticle (SeNPs) produced by exploiting the selenite 
reduction capability of two bacterial environmental isolate (Bacillus mycoides 
SeITE01 (Bm) and Stenotrophomonas maltophilia SeITE02 (Sm)) and compared 
to the one of chemically synthesized SeNPs (Ch-SeNPs). 
The ability of Bm-SeNPs(+) and Sm-SeNPs(-) to inhibit bacterial growth was 
initially tested against different clinical isolates from Pseudomonas aeruginosa 
species. Sm-SeNPs(-) showed the greatest antibacterial activity, with low MIC 
values against some of the strains tested, and a relevant antibiofilm activity, both 
in inhibiting the formation and disaggregating the mature EPS matrix. 
NPs with similar dimension and characteristics but originating from 
taxonomically different bacterial species, showed a different antimicrobial and 
antibiofilm activity. Due to the SeNPs mechanism of secretion, the NPs are 
characterized by having an organic layer coating their surface that seems to be 
involved in the nanoparticle mechanism of action. 
We demonstrated that the progressive coating denaturation cause an increasing 
loss of NPs antimicrobial activity. Sm-SeNPs(-) were subjected to different 
denaturing treatments (10%SDS, 10%SDS+10’boiling, 10%SDS+30’boiling) able 
to disaggragte the biogenic coating layer on their surface, and the antimicrobial 
and antibiofilm activity of the obtained NPs was tested against a large panel of 
Gram-negative and Gram-positive species. The results showed an increasing MIC 
value corresponding to a progressively strongest denaturing treatment. The 
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antibiofilm activity of the SeNPs was greater when the complete coating was 
present on their surface. Moreover, despite the poor knowledge about the 
mechanism of action of these nanomaterials, according to literature, we 
demonstrated that during the treatment with SeNPs, the planktonic form of the 
strains tested produced a large amount of ROS. 
The possible synergic activity of Sm-SeNPs in association with antibiotics was 
evaluated focusing on MDR clinical isolates of P. aeruginosa and S. aureus. In 
general, the SeNPs showed a grater activity than the antibiotics alone, only for the 
MDR P. aeruginosa INT strain the combination of biogenic SeNPs and 
antibacterial drugs evidenced a synergistic activity. 
Finally, the antibiofilm activity of Sm-SeNPs(-) was tested on different complex 
in vitro and in vivo models, confirming the potent antibacterial activity of the NPs 
tested and their inability to cause damage in human cell cultures and in the mouse 
model. Despite the poor knowledge about the mechanism of action of these 
nanomaterials, the results obtained provide interesting inputs to consider SeNPs as 
a novel and alternative antimicrobial strategy to treat challenging microbial 
infections such as biofilm-associated infections and those caused by MDR 
bacteria.  
 
 
 
 
 
 
 
 
 
 
 
 
 
8 
 
TABLE OF CONTENTS
 
1. ABBREVIATIONS...................................................................................pag.18 
2. RATIONAL AND OBJECTIVE OF THE STUDY...............................pag.19  
3. INTRODUCTION.....................................................................................pag.20 
3.1 Bacterial biofilms........................................................................pag.20 
The process of biofilm formation and its complex architecture........ .pag.21   
The importance of biofilm related infections in the clinical practice..pag.26 
3.2 Innovative anti-biofilm treatments and alternative  
approaches.........................................................................................pag.28  
Strategies for combating persisters......................................................pag.28 
Phage therapy......................................................................................pag.29  
Quorum Sensing inhibitors..................................................................pag.30 
Nanotechnology.................................................................................. pag.32 
3.3 Selenium nanoparticles...............................................................pag.35 
Mechanisms of microbial SeNPs synthesis.........................................pag.36 
Antimicrobial and antibiofilm activities of Selenium nanoparticles...pag.39 
Coating medical devices with SeNPs to prevent bacterial colonisation  
and biofilm formation..........................................................................pag.40 
Cytotoxicity and other possible applications for SeNPs.....................pag.40 
4. MATERIALS AND METHODS.............................................................pag.42 
4.1 Preparation and characterization of Selenium 
nanoparticles......................................................................................pag.42 
Preparation of Biogenic Selenium Nanoparticles (SeNPs).................pag.42 
Cell free extracts and CFX-SeNPs preparation...................................pag.42 
Scanning electron microscopy (SEM).................................................pag.43 
Dynamic Light Scattering (DLS) Analysis.........................................pag.43 
Quantification of proteins and carbohydrates still remaining on the NPs 
surface after different denaturing treatment…………………………pag.44 
4.2 Antimicrobial and antibioiflm activity of Selenium nano- 
particles……………………………………………………………..pag.44 
Growth conditions and Microbial strains...........................................pag.44 
9 
 
Determination of the minimum inhibitory concentration (MIC) of biogenic  
NPs.......................................................................................................pag.47 
Biofilm formation assay......................................................................pag.47 
Biofilm inhibition and disintegration assay for biogenic SeNPs.........pag.48  
Biofilm formation and treatment with different types of 
SeNPs...................................................................................................pag.48 
Quantification of the biofilm biomass (Crystal Violet assay, CV 
assay)...................................................................................................pag.48 
Quantification of surviving cells.........................................................pag.49  
Reactive Oxygen Species production assay (ROS assays)..................pag.49 
4.3 Evaluation of the synergic effect of biogenic SeNPs and 
antibiotics...........................................................................................pag.50 
Microbial strains and growth conditions.............................................pag.50 
Drugs and antibiotics used...................................................................pag.50 
Determination of minimum inhibitory concentration and fractional 
inhibitory concentration (FIC).............................................................pag.50 
Biofilm formation and treatment with combination of SeNPs and 
antibiotic..............................................................................................pag.51 
Quantification of cells.........................................................................pag.51 
Quantification of the biofilm biomass (Crystal Violet assay, CV 
assay)...................................................................................................pag.52 
4.4 Chronic in vitro wound model....................................................pag.52 
Day 1 (first layer)................................................................................pag.52 
Day 2 (second layer)............................................................................pag.52 
Set up of the infection protocol...........................................................pag.53 
Determination of the minimum inhibitory concentration (MIC) of biogenic 
NPs.......................................................................................................pag.54 
4.5  Flow cells growth model............................................................pag.54 
Quantification of cells in biofilms.......................................................pag.56 
4.6 Caenorhabditis elegans: a simple “in vivo” model....................pag.56 
Preparation of Nematode Growth Medium (NGM) plates..................pag.56 
Preparation of bacterial food source (E. coli OP50)............................pag.56 
10 
 
Transferring the worms (“chunking” technique).................................pag.57 
Obtaining a synchronised C. elegans population (“bleaching”)..........pag.57 
C. elegans infection assay...................................................................pag.57 
4.7 Fluorescence microscopy............................................................pag.58 
4.8. SeNPs toxicity in an in vivo mouse model................................pag.58 
Intratracheal challenge of Sm-SeNPs(-)……………………………..pag.58 
4.9 Evaluation of SeNPs cytotoxic effect in human cell 
cultures...............................................................................................pag.59 
Preparation and culture of dendritic cells and fibroblasts...................pag.59  
Quantification of cytokine production.................................................pag.59 
Cell viability evaluation.......................................................................pag.60  
4.10 Statistical analysis.....................................................................pag.60 
5. RESULTS..................................................................................................pag.61 
5.1 Biogenic selenium nanoparticles: characterization, antimicrobial 
and antibiofilm activity.....................................................................pag.61 
Determination of Minimum Inhibitory Concentration (MIC) for SeNPs 
against P. aeruginosa PAO1...............................................................pag.63 
Antimicrobial activity of SeNPs against clinical isolates of  
P. aerginosa………………………………………………………….pag.65  
Inhibition of P. aeruginosa strains biofilm formation by 
SeNPs…...……………………………………………………………pag.68
Degradation of P. aeruginosa biofilms by 
SeNPs...................................................................................................pag.68 
Antimicrobial activity of SeNPs against clinical isolates of Candida  
spp………….………………………………………………………...pag.71 
Inhibition of the formation and degradation of Candida strains biofilm by 
SeNPs ………………………………………………………………..pag.71  
5.2 Investigation of the biogenic coating as a possible modulator for 
the SeNPs antimicrobial and antibiofilm 
activity………………...……………………………………………pag.73 
Characterization of Sm-SeNPs(-) as biogenic products and after different 
treatments…………………………………………………………….pag.74 
11 
 
Characterization and antimicrobial activity for Sm-SeNPs(48)……..pag.77 
Antimicrobial activity of the various kinds of  Selenium NPs............pag.78 
Anti-biofilm effect of native and treated Sm-SeNPs(-).......................pag.81 
Fluorescence microscopy....................................................................pag.85 
ROS production...................................................................................pag.87 
5.3 Evaluation of the possible synergic effect of biogenic selenium 
nanoparticles and antibiotics...........................................................pag.87 
Antibiofilm activity of different combination of SeNPs and  
antibiotics.............................................................................................pag.89 
5.4 Evaluation of the antibiofilm activity of biogenic senps in complex 
“in vitro” and “in vivo” models.......................................................pag.92 
Chronic wound model.........................................................................pag.92 
 Flow cells............................................................................................pag.96 
Caenorhabditis elegans.......................................................................pag.99 
Mouse model.....................................................................................pag.101 
5.5 Effects of biogenic selenium nanoparticles on human dendritic 
cells and fibroblasts.........................................................................pag.102 
Evaluation of cell viability................................................................pag.102 
Quantification of cytokine production...............................................pag.104 
6. DISCUSSION..........................................................................................pag.106 
7. CONCLUSION AND PERSONAL CONSIDERATIONS..................pag.115 
8. AKNOWLEDGMENTS.........................................................................pag.117 
9. BIBLIOGRAPHY...................................................................................pag.118 
10. SCIENTIFIC CONTRIBUTION FROM THE PhD THESIS..........pag.127 
 
 
 
 
12 
 
1. ABBREVIATIONS 
AD, Artificial Dermis 
Bm-SeNPs(+), Selenium nanopaticles 
produced by Bacillus mycoides SeITE01 
BSA, Bovine Serum Albumin 
Ch-NPs, chemical nanoparticles 
CF, Cystic Fibrosis 
CFU, Colony Forming Unit 
CFX, Cell Free Extracts 
CLA, Clarithromycin 
CLSI, Clinical and Laboratory Standards 
Institute  
CV, Crystal Violet staining  
DCs, dendritic cells 
DLS, Dynamic Light Scattering 
EDAX, Energy Dispersive X-ray 
Analysis 
FICI, Fractional Inhibitory 
Concentration Index 
FTIR, Fourier Transform Infrared 
spectroscopy 
GM-CSF, Granulocyte-Colony 
Stimulating Factor  
HA, Hyaluronic Acid 
H2DCF-DA, dichlorodihydrofluorescein 
diacetat  
HMW, High-Molecular Weight 
IL,  interleukin 
MDR, Multi Drug Resistant  
MIC, Minimum Inhibitory concentration 
MTP, microtiter plate 
NGM, Nematode Growth Medium 
NPs, nanopartcles 
OD, Optical Density                                             
O/N,overnight  
PDI, Polydisperity Iindex 
PS, Physiological Saline 
ROS, Reactive Oxygen Species 
SeNPs, selenium nanoparticles 
Sm-SeNPs(-), Selenium nanopaticles 
produced by Stenotrophomonas 
maltophilia SeITE02 
Sm-SeNPs(48), Selenium nanoparticles 
produced by S. maltophilia SeITE02 
after 48 hours of incubation with sodium 
selenite. 
SEM, Scanning Electron Microscopy 
SEM, Standard Error Mean 
SD, Standard Deviation 
SDS, Sodium Dodecyl Sulfate 
TRIM, Trimethoprim/Sulfametoxazole 
TSB, Tryptic Soy Broth 
TSA, Tryptic Soy Agar 
VAN, Vancomycin 
WT, Wild Type 
LEV, Levofloxacine 
LPS, lipopolysaccharide 
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 2. RATIONAL AND OBJECTIVE OF THE STUDY
 
Aim of this study was to evaluate the antimicrobial activity of biogenic produced 
Selenium nanoparticles in order to find a possible alternative strategy in the 
fighting against antibiotic resistance. Biofilm-forming pathogens have been 
shown to associate with a wide range of chronic human diseases and an important  
characteristic of these chronic biofilm-related infections is the extreme resistance 
to antibiotics. The emergence of nanotechnology leaded to new antimicrobial 
options, suggesting the use of nanomaterials as complementary agents to 
antibiotics.  
This three years PhD project is the result of a multidisciplinary collaboration 
between different Department of the University of Verona and, some parts of the 
study, have seen the contribution of the Laboratory of Pharmaceutical 
Microbiology, leaded by Prof. Tom Coenye, at Ghent University, Belgium. The 
Selenium nanoparticles used, were produced by the research group of Prof. 
Giovanni Vallini, in the Environmental Microbiology Laboratory, Department of 
Biotechnology, University of Verona.  
That to underline how important the collaborations with other research areas 
could be. In our case, microorganisms capable of transforming the toxic Selenium 
oxyanion into non-toxic elemental Selenium could be considered as biocatalysts 
for the production of nanomaterials (SeNPs), eventually exploitable in different 
biotechnological applications. Especially in the clinical practice, where the lack of 
new antimicrobial molecules and the increasing onset of drug-resistant bacterial 
strains, lead to the necessity of alternative therapeutic strategies. An 
environmental beneficially process turned out to be a biocompatible product that 
could be administered to inhibit the growth of pathogens, including those resistant 
to antibiotics. 
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3. INTRODUCTION 
 
3.1 BACTERIAL BIOFILMS 
Marshall, in 1976, noted the involvement of “very fine extracellular polymer 
fibrils” that anchored bacteria to surfaces. However, the term “biofilm” was used 
for the first time by Costerton in 1981 to describe the way of growth of some 
bacterial aggregates and only in 1984 was cited the relationship between human 
infections and bacterial biofilms (Bjarnsholt, 2013). Before that, was 
Leeuwenhoek that examining the “animalcules” in the plaque on his own teeth in 
the late seventeenth century, for first introduced the general idea that the sessile 
bacterial cells differ profoundly from their planktonic floating counterparts 
(Donlan, 2002). The observation of natural aquatic ecosystems and the direct 
quantitative recovery techniques, showed then that more than 99.9% of the 
bacteria are able to grow in biofilms on a wide variety of surfaces (Costerton, 
1995). The definition of the term “biofilm” has deeply evolved from the first 
observations to our days, to accommodate new knowledge. Starting from the 
already mentioned study of attached bacterial communities in aquatic systems 
encased in a “glycocalyx” matrix, that Costerton and collaborators hypothesized 
important for the bacterial adhesion (Costerton, 1978), going to the statement that 
biofilm consists of single cells and microcolonies, all embedded in a highly 
hydrated, predominantly anionic, exopolymer matrix (Costerton, 1995). In 1990 
Characklis and Marshall defined other aspects of biofilm-way-of-growth, such as 
the typical spatial and temporal heterogeneity and the presence of inorganic or 
abiotic substances held together in the biofilm matrix. Moreover, Costerton et al., 
(1995) emphasized the characteristic of biofilms adhering to surfaces and 
interfaces, and to each other, including microbial aggregates such as floccules and 
adherent populations within pore spaces of porous media. Finally, by Costerton 
and Lappin-Scott, was introduced the concept that adhesion elicit expression of 
genes controlling the production of bacterial components, necessary for biofilm 
attachment and formation. Emphasizing in this way, that the process of biofilm 
formation was regulated by specific genes transcribed during initial cell 
attachment (Ciofu, 1994). Recently, has been hypothesized that biofilms can grow 
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without being attached to a surface and that part of the esopolysaccharide matrix 
could originate from the host (Bjarnsholt, 2013).  
Because bacterial biofilms cause very serious problems in industrial water 
systems, this field have been the first where the researchers tried to develop 
methods and strategies to control their costly depredations (Costerton, 1987). In 
the medical field, most, if not all, relevant microorganisms, including Gram-
positive and Gram-negative bacteria, both aerobic and anaerobic, mycobacteria 
and fungi can form and grow in biofilms (Cuellar-Cruz, 2012).   
 
The process of biofilm formation and its complex architecture          
 
 
Figure 1. Different stages of biofilm formation (Center for Biofilm Engeneering, 
Montana State University). 
 
Usually, we can divide the process of biofilm formation in three different and 
subsequent steps. A single free-floating cell can adhere to a surface and start to 
replicate forming a microcolony (phase of attachment) that can grow and develop 
into an organized community (phase of growth). The possible transition from 
planktonic mode of growth to the biofilm one, seems to occur in response to 
environmental changes (Kostakioti, 2013). The initial attachment, mediated by 
pili, fimbers and adhesions, is a reversible and dynamic process that can follow 
different phases in which the bacterial cells can detach and rejoin the planktonic 
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form in response to different stimuli (e.g. repulsive forces, nutrient limitation) 
(Dunne, 2002). From the sessile mature form of the biofilms,  non-sessile 
planktonic individuals bacteria, can disperse and rapidly multiply or colonize 
other surfaces (i.e. detachment).  
Inside their niche, bacteria can encounter different attractive or repelling forces, 
depending on nutrient levels, pH, ionic strength, and temperature. Moreover, the 
properties of different types of medium, combined with the composition of 
bacterial cells surface, could affect the velocity and direction toward or away from 
the contact surface (Kostakioti, 2013). Motile bacteria seems to have a 
competitive advantage for the presence of flagella used to overcome 
hydrodynamic and repulsive forces. Indeed, for a number of pathogens as 
Pseudomonas aeruginosa, Vibrio cholerae, Listeria monocytogenes, and 
Escherichia coli as been reported the importance of flagellar motility for their 
initial attachment (Kostakioti, 2013). Schmit et al. (Schmit, 2011), demonstrated 
that also chemotaxis plays a relevant role in directing the microbial attachment in 
response to nutrient changes. In the case of P. aeruginosa, mutations in the CheR1 
methyltranferase have been show to alter the aminoacid response with the result to 
impair cells attachment and biofilms maturation. 
 
Bacteria can coordinate their growth within the biofilm structure using the 
complex communication system known as Quorum Sensing (QS), a cell-density-
dependent gene expression mechanism regulated by the excretion of small 
signalling molecules (Brackman, 2015). When these released molecules reach a 
certain extracellular threshold concentration, they bind a receptor, activating the 
QS system. Both Gram-negative and Gram-positive bacteria have a typical QS 
system. The first consists in a system made by three fundamental components a 
synthase homolog (LuxI), an acyl-homoserinelactone (AHL) signalling 
molecules, and a LuxR receptor homolog (Fuqua, 2002). In P. aeruginosa, as an 
example, many genes are regulated and expressed by the QS system including 
those having a role in pathogenesis and encoding for alkaline protease, pyocyanin, 
pyoverdine, cyanide, lipase, twitching movement, alginate production, etc, ... (Al-
Wrafy, 2017).  
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On the contrary, Gram-positive bacteria generally use small peptide signalling 
molecules, that when transported out of the cell, bind to a membrane-associated 
two-component receptor (Williams, 2007). This binding to the receptor, activates 
a signal transduction system leading to the transcription of QS-regulated genes. 
Moreover, there is a third QS system, used in both Gram-positive and Gram-
negative bacteria, that include the use of an auto-inducer (AI-2) as signalling 
molecule and is considered to be responsible for interspecies communication 
(Xavier, 2003).  
The Quorum Sensing system seems also to be responsible for the regulation of 
biofilm formation in several bacterial species. Different research project 
highlighted how the biofilm structure and the formation process by mutant forms 
of different Gram-negative bacterial species is drastically altered (Brackman, 
2015). Similar results were observed when the same bacterial species 
(Burkholderia multivorans, B. cenocepacia, and P. aeruginosa) were treated with 
some QS inhibitors (QSI) (Brackman, 2009). As regard Gram-positive bacteria, 
there is the evidence that in Staphylococcus aureus biofilm formation, is enhanced 
by the agr QS system, while hamamelitannin, a non-peptide analog of the RNAIII 
inhibiting peptide, decreases S. aureus attachment both in  in vitro and in vivo 
models (Brackman, 2016; Boles, 2008). For these reasons, QSI can be considered 
as promising antibiofilm agents that could be used as a novel alternative strategy 
in fighting biofilm-related infections. However, very little is known about the 
relationship between the antibiofilm effect of QSI and the susceptibility of 
biofilms to antibiotics (Brackman, 2015).  
 
The self-produced viscoelastic exopolymeric matrix (EPS) that cover this 
complex bacterial community, constitute a protection to this mode of growth that 
allows the survival of the bacterial cells in hostile environments (Costerton, 
1999). Typically, the matrix is composed for 90% of the dry mass of biofilms 
compared to just 10% for the bacteria (Kundukad, 2016). We could define the 
EPS as a cross-linked three-dimensional architecture made up of different 
polymers as polysaccharides, nucleic acids, proteins and other macromolecules 
that facilitate biofilm formation and maintenance. Furthermore inside the matrix 
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we could find adhesive fibers as pili and flagella, and extracellular DNA (eDNA), 
with the stabilising function for the three-dimensional biofilm structure 
(Kostakioti, 2013). Research has shown that eDNA, not only does have a 
significant role in stabilizing the structure of  biofilms, but it also promotes 
tolerance to antimicrobial peptides and aminoglycosides by chelating cations and 
restricting diffusion of cationic antimicrobials (Cao, 2015). 
Inside the matrix, a complex structure with channels that allow the circulation of 
nutrients, and different regions that could host different cells with various pattern 
of gene expression, define the physicochemical properties of biofilm structure as 
well as contribute to the key properties such as antibiotic resistance and processes 
including detachment. The heterogeneity within the biofilm structure mediates the 
penetration of the nutrient flow while protects the dormant persister cells against 
the activity of antibiotic (Thomsen, 2017). Indeed, EPS biopolymers are highly 
hydrated and the matrix formed is able to keep the biofilm cells together and 
retains water. Different studies have also shown that metabolically inactive and 
non dividing persister cells that we can found within biofilms, can be tolerant to a 
number of antibiotics despite the fact that they are genetically identical to the rest 
of the bacterial population (Lewis 2005, 2008). In this contest, is also facilitated 
the process of horizontal gene transfer, since the cells are maintained in close 
proximity to each other not fully immobilized, and can exchange genetic 
information (Flemming, 2007). Thus leading to an increase of the presence and 
exchange of genes related to antibiotic resistance.  
 
The EPS matrix contributes to the protection of the cells from environmental 
stresses (Kundukad, 2016). On the other hand, has a key role also in facilitating 
the cell to cell interactions, including the communication between different 
bacterial species (Kostakioti, 2013).  
In this contest, we have to mention dental plaque, one of the most clear example 
of mixed species biofilm community. The close relationship between different 
cells inside the plaque and the ability of these microorganisms to interact with 
neighbourhood build up a benefit for the community way of growth. As an 
example, oxygen consumers and oxygen sensitive microorganisms are closely 
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related: the first ones create conditions that are suitable for the proliferations of 
the others (Marsh, 2011). Moreover, mutualistic interactions were also detected in 
the catabolism of complex molecules (Bradshaw, 1994). In response to these 
complex metabolic processes, the spatial distribution and organisation of the 
interacting bacteria varies significantly in the various mouth districts emphasizing 
the role of  the habitat properties in the biofilm community composition (Marsh, 
2011). The presence of mixed biofilms of Streptococcus mutans, Prevotella 
species and Fusobacterium species, to list few microorganisms, and other bacteria 
can cause caries, periodontitis and severe gingivitis (Kuramitsu, 2011). 
 
Another important structural component  of  the biofilm matrix, typical of Gram-
negative bacteria is the lipopolysaccharide (LPS), a complex glycolipid that forms 
part of the outer membrane of the cell wall. This molecule plays a role in 
antigenicity, inflammatory response and in mediating interactions with antibiotics. 
LPS contributes to biofilm function, architecture and integrity by influencing 
bacterial cell-to-cell adhesion and viscoelastic properties of biofilms (Al-Wrafy, 
2017).  
 
The heterogeneity in metabolic and reproductive activity within a biofilm 
correlates with a non-uniform susceptibility and a nutrient limitation that represent 
one of the most important cause of starvation induced tolerance  (Anutrakunchai,  
2015). Nutritional starvation and high cell density, two key characteristics of 
biofilm physiology, are important factors in mediating the antimicrobial tolerance 
(Fux, 2005). Recently, Mlynarcik et al. (Mlynarcik, 2017), demonstrated that 
nutrient deprivation contribute to the increased tolerance of P. aeruginosa cells 
through the production of persisters cells. Moreover, starvation-induced growth 
arrest cause an inactivity of the antibiotics target (Nguyen, 2011).  
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The importance of biofilm related infections in the clinical practice 
 
Figure 2. Partial list of human infections involving biofilms (Costerton, 1999). 
 
Bacterial biofilms can form and grow on different biotic surfaces and, as already 
mentioned, are the main cause of different recalcitrant infections that could be 
difficult to treat, and affect various district of the human body. Gram-negative and 
Gram-positive oral bacterial species are the main cause of dental plaque and 
periodontitis, an infection of the gum. The biofilm-based infections recurrent in 
the lungs of patients affected by cystic fibrosis (CF), in otitis media or in chronic 
wounds are able to get the nutrients required for the microorganisms growth from 
the blood stream, the interstitial fluid in tissues or lungs (Bjarnsholt, 2013). 
Especially in CF patients, the presence of a “slime” in the sputum of affected 
people, allow the formation and the protection of bacterial aggregates able to 
colonize the lung of these patients. Recurrent in these cases are the infection of 
opportunistic pathogens as P. aeruginosa or Burkholderia complex species. The 
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presence of P. aeruginosa mucoid alginate producing strains, confer an enhanced 
resistance to antibiotics, phages, host immune system, and is detected in the 
majority of CF patients (O'Brien, 2017). Despite the aggressive treatment of the 
infections, that bacterial cells can persist in the CF lung causing a continuous 
degradation of the lung tissues.  Consequently, the inflammatory process leads to 
a decline in lung function, the primary cause of death in CF patients (Bjarnsholt,  
2013).  
Different studies highlighted how the CF lung airways can be affected by a 
polymicrobial infections that vary in their composition and diversity throughout a 
patient's lifetime (Magalhães, 2016; Moran Losada, 2016, Paganin, 2015). Social 
interactions between the different bacterial species evidence that interactions 
within and among species can alter virulence properties of  P. aeruginosa both in 
the short term in the evolution of this pathogen in the long term disease (O’Brien, 
2017). 
 
Different nosocomial infections are caused by a variety of microorganisms that 
can colonize various medical devices as endotracheal tubes, urinary or venous 
catheters, orthopaedic devices and joint prosthesis. The types of bacteria 
responsible for this unpleasant condition are Streptococcus species, S. aureus, S. 
epidermidis, and regarding the Gram-negative, Pseudomonas, Enterococcus and 
Candida spp. The origin of the infections may derive from the patient skin (Jamal, 
2017). In these kind of infections, the “recalcitrance” of bacterial cells embedded 
in the biofilm matrix, is the main cause for the failure of antibiotic therapy and the 
infection recurrence. The recalcitrant biofilm cells, able to survive inside the host 
also in presence of high concentration of antibiotics, could spread in the human 
body and colonize other districts (Lebeaux, 2014).  
Especially in immune-compromised patients, the manifestation of infections by 
opportunistic biofilm-forming pathogens can be a main concern, leading to 
devastating symptoms and, in last instances, death.  
The tolerance of bacterial biofilms to antimicrobial compounds is based on a 
multifactorial physical, physiological and adaptive mechanisms that allows 
biofilm cells to sustain a long-term exposure to antimicrobial agents without loss 
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of viability. The physical tolerance is based on the complex tridimensional 
structure of the EPS matrix, widely described above. On the other hand, the 
physiological side of the biofilm tolerance is caused by the metabolic state of 
nutritional starvation. Finally, adaptive mechanisms of induced tolerance can be 
considered all the transient refractory subpopulations of bacterial cells in biofilm 
which appear in response to the presence of a specific antimicrobial agent. 
We can generally assert that the tolerance of mature biofilms is often 1000 times 
higher against most antimicrobial agents, including antibiotics and detergents, if 
compared with their planktonic counterparts (Bjarnsholt, 2013). 
 
 
3.2 INNOVATIVE ANTI-BIOFILM TREATMENTS AND ALTERNATIVE 
APPROACHES  
Conventionally used antibacterial drugs are active against the planktonic form of 
bacterial cells responsible for the acute phase of infection but they fail in the 
completely eradication of biofilms, leading to the persistence of the disease 
(Bjarnsholt, 2013). For that reasons there is an urgent need to develop novel 
antibiofilm strategies that can replace or potentiate conventional antimicrobial 
agents. The use of combined antibiotic therapy is a strategy often employed also 
in the treatment of multi drug resistance (MDR) infections. Bacterial strains 
resistant to the antibiotics now in use have become a serious public health 
problem that increases the need to develop of new bactericidal materials. 
 
Strategies for combating persisters 
Due to their structural composition,  biofilms restrict the penetration of antibiotics 
forming a barrier that protect the cells from the environment. However, the 
presence of a biofilm-specific resistance mechanism, responsible for recalcitrant 
infectious diseases, has been hypothesized (Lewis, 2010). After a treatment with 
an antibiotic, able to kill the majority of the cells within the biofilm, a small 
fraction of cells, called “persisters”, is able to remain alive. This surviving 
population is now able to re-establish the biofilm community, causing a chronic 
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infection. Once awakened, the bacterial cells are again capable to initiate infection 
(Mina, 2016). Persister dormant bacterial cells are especially significant in those 
sites were the immune components are limited (e.g. in the nervous system) or are 
less effective as in immune-compromised patients (Lewis, 2012).  
Different microbial biotechnological approaches have been developed to kill 
sleeping cells resistant to traditional antibiotics (e.g. fluoroquinolones, 
aminoglycosides and β‐lactams). These kind of approaches could exploit the 
ability of certain compounds to enter the EPS matrix and consequently the 
bacterial cell, without the need of active transport, to finally kill the persister cells 
(Wood, 2017).  
Another alternative approach could be the one to wake dormant cells and then 
treat them with traditional antibiotics adding sugars and glycolysis intermediates 
(e.g. mannitol, glucose, fructose, pyruvate) able to rapidly wake persisters 
(Allison, 2011). Similarly, P. aeruginosa persister cells may also be awakened 
with cis-2-decenoic acid, which causes a burst in protein synthesis, and then killed 
by ciprofloxacin (Marques, 2014). In the same way, S. aureus persister cells can 
be efficiently awakened using cis-2-decenoic acid, and, once in a non-dormant 
state, show a loss of tolerance to ciprofloxacin (Mina, 2016). Apply a treatment in 
order to avoid the production of reactive oxygen species, may help the antibiotic 
treatment against Bulkhoderia cepacia complex biofilms (Van Hacker, 2013). 
Mehemet and collaborators (Orman, 2016), demonstrated that the treatment with 
nitric oxide (NO) at the onset of stationary phase, significantly reduced E.coli 
persister cells formation through its ability to inhibit respiration.  
Recently, some anticancer molecules have been suggested to be effective in vitro 
for eliminating recalcitrant, multidrug tolerant bacteria. Thus, due to the 
similarities between cancer cells and bacterial infections, 5-fluorouracil (5-FU), 
gallium (Ga) compounds and mitomycin C revealed some promising properties 
such as broad activity (all three compounds), dual antibiotic and antivirulence 
properties (5-FU), efficacy against multidrug resistant strains (Ga), and the ability 
to kill metabolically dormant persister cells which cause chronic infections 
(mitomycin C) (Soo, 2017).  
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Phage therapy  
The increasing need of novel and effective treatments to target the complex 
biofilm structures has led to a growing interest on bacteriophages (phages) as a 
strategy for biofilm control and prevention (Pires, 2017). The ability of lytic 
phages to target specifically bacteria and kill these cells embedded in the biofilm, 
with no effect on commensal flora, suggest the potentiality in the use of this 
strategy as well as against antibiotic resistant strains (Al-Wrafy, 2017). However, 
there is still a limited knowledge about the phages mechanism of interaction with 
the population that compose the bacterial biofilm (Pires, 2017). Recently, relevant 
studies were conducted to evaluate the possible use of phage therapy in the 
treatment of chronic lung infections (Waters, 2017; Abedon, 2015), showing the 
possibility to use this innovative strategy as an alternative treatment against P. 
aeruginosa lung infections, in several cases associated with Cystic Fibrosis. 
Moreover, numerous in vitro experiments have demostrated that genetically 
engineered phages are able to infect biofilm cells causing a production of 
depolymerases with the final advantage of penetrate the inner layers of the biofilm 
and degrading components of the EPS matrix (Azeredo, 2008). Evidence 
suggested also the use of phage therapy in the treatment of post-burn infections 
caused by opportunistic pathogens as E. coli, P. aeruginosa, S. aureus and 
Klebsiella pneumoniae (Ahmad, 2002).  
Bacteriophages can be modified to have an extended host range or a longer 
viability in the mammalian bloodstream, enhancing their potential as 
an alternative to conventional antibiotic treatment. They can also be engineered to 
transfer various compounds applicable for drug or gene delivery or an insertion of 
an active depolymerase genes could enforce the biofilm disaggregation  (Bàrdy, 
2016). Although a bacterial resistance to phages is already well known, a use of 
phage cocktails could overcome this problem, especially in the treatment of 
wound infections (Chhibber, 2017; Chadha, 2016). The use of a such mixed 
therapy could be also more effective in reducing the frequency of bacterial 
mutation in multi-drug resistant infections (Gu, 2012). 
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Quorum Sensing inhibitors 
Suppressing the cell-to-cell Quorum Sensing communicating system within the 
bacterial biofilm, could be another promising antimicrobial strategy for the 
treatment of challenging infections and the prevention of biofilm formation. 
Different strategies have been proposed, here are reported some examples.  
Efflux pumps play an important role in the exclusion or inclusion of quorum-
sensing-biomolecules necessary for biofilm formation. Altering the functioning of 
these pumps may interrupt the molecular traffic inside and outside the bacterial 
cell. The application of metallic nanoparticles as efflux pump inhibitors could 
represent a potential candidate to reduce biofilm-forming capacity of microbes 
and could also help the bactericidal effect of conventional antibiotics (Gupta, 
2017). 
Hammamelitanin (HAM), was discovered for the first time in a virtual screening 
of a library of small molecules based on RNAIII inhibiting peptide (RIP). This 
small molecules demonstrated able to block the QS system in S. aureus and affect 
biofilm formation causing altered cell wall synthesis and extracellular DNA 
(eDNA) release. Moreover, HAM can increase the susceptibility of S. aureus 
biofilms towards different classes of antibiotics (Brackamn, 2016). 
Streoptococcus mutans quorum qensing pathway can be effectively inhibit, 
interfering with the peptidase (PEP) domain contained in the ATP-binding 
cassette transporter ComA. Via an high-throughput screening, Ishii and 
collaborators (Ishii, 2017), found potent small molecules able to attenuate S. 
mutans biofilm formation and development without inhibiting bacterial cell 
growth. 
The autoinducer acyl-homoserine lactones (AHLs) signalling molecules can be 
inhibit by various glucosamine monomers. Some strains of P. aeruginosa and E. 
coli demonstrated to be particularly sensitive to this mechanism (Biswas, 2017).  
Quorum sensing can be inhibit also altering the  autoinducer-binding receptors as, 
LasR and RhlR. Flavonoids are able to prevent the binding of LasR/RhlR DNA in 
a non competitive way, resulting in a suppression of virulence factor production in 
P. aeruginosa strains (Paczkowski, 2017).  
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Enterococcus faecalis is an opportunistic pathogen, naturally present in the 
gastrointestinal tract of humans and animals, able to cause urinary tract infections, 
bacteraemia, prosthetic joint infection, abdominal-pelvic infections, and 
endocarditis.  
E. fecalis quorum-sensing systems could be inhibited by focusing specifically on 
the autoinducers (GBAP and CylLS) and their receptors. Autoinducer-antagonists 
are able to interact with specific receptors and do not exert selective pressure like 
antibiotics, without interfering with the normal host flora (Ali, 2017). 
Natural compounds as plant extract could also be considered an alternative to the 
usual clinical practice. Recently, Al-Haidari and collaborators (Al-Haidari, 2016), 
tested different plant extract of Citrus sinensis, Laurus nobilis, Elettaria 
cardamomum, Allium cepa, and Coriandrum sativum as quorum quenching 
inhibitors, demonstrating a potent effect. These extracts exhibited significant anti- 
QS activity, acting on pyocyanin formation, twitching and swimming motility, 
and biofilm development of P. aeruginosa PA14 strain.  
 
Nanotechnology  
Novel antibiotic drug delivery system are gaining importance for the urgent need 
to develop new efficient strategies to target microbial biofilms and resistant 
bacteria. Recently, a wide range of nanoparticles (e.g. silver, gold, iron oxide) 
have been intensively studied as antimicrobial agents, including their use against 
multidrug-resistant bacteria (Wang, 2017; Taylor, 2011). Some authors reported 
the use of these nanomaterials as a delivering strategy to improve their therapeutic 
efficacy challenging the developing resistance of the pathogens (Shaker, 2017; 
Bagga, 2017). Conjugating nanoparticles with an unresponsive antibiotic could be 
a possible strategy to restore its efficacy against otherwise resistant microbes 
(Shaikh, 2017; Li, 2014). The combined therapy might fill the gap where common 
chemotherapy fail (Beyth, 2015). A such novel synergistic approach can be 
applied to treat biofilm infections facilitating the penetration of the conventional 
agents within the exopolysaccharide matrix and inducing the microbes into their 
planktonic status thus targeting bacterial growth (Kostakioti , 2013) or inducing 
biofilm dispersion (Shafiei, 2013).  
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The relevant characteristic about the possible use of these nanomaterials is related 
to combating antibiotic resistance mechanisms. Indeed, in contrast to traditional 
antibiotics, where the resistance paths are usually relatively simple, NPs could 
combat microbes via multiple mechanisms simultaneously active. The advantage 
of this line of action is that microorganisms are unlike to have multiple related 
genes, consequently is much more difficult to develop a resistance to 
nanoparticles (Wang, 2017). Peculiar features of the NPs that represent an 
advantage for their antibacterial activity are the size: ultra-small and controllable 
size of nanoparticles is suitable also for the treatment of intacellular bacterial 
infections (Ranghar, 2012). Current research has demonstrated that the size of 
metal NPs can greatly affect its antibacterial activity (Esfandiari, 2014).  
The shape is another important factor related to nanoparticles antimicrobial activ-
ity. NPs with different shapes can cause varying damages in bacterial cells 
through interactions with periplasmic enzymes (Cha, 2015).  
Finally, we have to mention the zeta potential, which as a strong influence on 
bacterial adhesion. Positively charged NPs, compared with negatively charged 
and neutral NPs counterparts, have been believed to enhance ROS production. 
Negatively charged NPs seems to not adhere to bacteria because to the negative 
potential on both sides. However, at high concentrations, negatively charged NPs 
have a certain level of antibacterial activity due to molecular crowding, which 
leads to interactions between the NPs and the bacterial surface (Arakha, 2015). 
 
The use on NPs as carriers for drug delivery, can help in the increasing of drug 
levels in the serum, protecting the drug molecules from chemical reaction until 
they reach their action site. Another important characteristic in the possible use of 
NPs as alternative strategies is their security: nanocarriers can target directly the 
infection site minimizing systemic undesired effects. Moreover, a controllable 
release of antibiotic could be possible (Wang, 2017). 
 
Nanomaterials are currently used as an antibacterial coating in different 
implantable devices, especially in dental implants, where nanopolymers can 
inhibit the adhesion and colonisation of different bacterial species (e.g. 
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Streptococcus mutans, Streptococcus epidermidis or E. coli). Partially implantable 
devices as catheters can be treated with nanomaterials to retard or prevent the 
formation of bacterial biofilms (Samuel, 2004).  
The treatment of chronic wound is another challenging side of microbial 
infections. A cover called a “dressing”, on which nanomolecules, as silver, can be 
added, could help reducing the risk of chronicity of wound infections and promote 
the proliferation of epithelial cells and the formation of new tissues (Yu, 2014). 
 
Although the antibacterial mechanism of these nanomaterials is not fully 
understood, different authors suggested some possible way of action. Currently, 
the most frequently proposed are oxidative stress, metal ion release and non-
oxidative mechanisms. 
The production of Reactive Oxygen Species (ROS) is an important antibacterial 
mechanism of NPs that leads to the induction of oxidative stress. Different types 
of NPs produce different types of ROS by reducing oxygen molecules. In normal 
conditions, the production and clearance of ROS in bacterial cells are balanced. 
When there is an excessive production of ROS, the redox balance of the cell 
favours oxidation, which produce a state of oxidative stress leading to the damage 
of bacterial cells (Wang, 2017). 
Metal ions can be released by metal oxide and penetrate into the bacterial cell. 
Inside the cell, metal ions can interfere with different physiological processes and 
in the end, resulting in bacteria death (Yu, 2014). Regarding the non-oxidative 
mechanisms of action assigned to NPs, relevant are the interaction with the 
bacterial cell wall, an important defensive barrier that protect the cell from the 
external environment. The ability of NPs to penetrate, through different 
mechanism, the cell membrane. The inhibiting activity of the synthesis of 
bacterial proteins and DNA and finally, the ability of inhbiting the biofilm 
formation (Wang, 2017). 
It has also been suggested that the EPS matrix enables sequestering of particles 
from the surrounding biofilm environment (Flemming, 2007), thus helping the 
NPs mechanism of action. Furthermore, the EPS has been described as a 
“honeycomb” like structure (Schaudinn, 2009) with pores of various sizes 
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potentially allowing preferential absorption of key nutrients and blocking 
penetration based on size, structure, or charges. While the mechanisms regulating 
particle uptake are not yet known, it has been shown that these mechanisms are 
strongly dependent on the surface nanoparticle ionization (Nevius, 2012). 
However, NPs antibacterial effects are not fully understood and their potential 
toxicity towards human tissues requires further investigation. Another potential 
limitation affecting the clinical application of metal/metalloid nanoparticles is the 
ability of some nanostructured materials to stimulate the release, by dendritic cells 
(DCs) and other cells in the immune system, of reactive oxygen species or 
chemical mediators able to cause unwanted side-effects such as hypersensitivity 
reactions or inflammatory responses (Di Gioacchino, 2011). Particularly, oxygen 
free radicals can cause severe tissue damage, and may also release cytokines that 
play a key role in the induction of inflammatory and immune responses (Donini, 
2007). Therefore, nanoparticle candidates suitable for clinical applications must 
not induce DC activation or have toxic effects against cells of the immune system 
and other tissues. 
 
 
3.3 SELENIUM NANOPARTICLES 
The increasing request of alternative antibiotic strategies and the recent 
developments in nanotechnology occurred in the last years, allow the production 
and the improvement of tailored metal/metalloid nanoparticles with 
physicochemical properties that can inhibit via different mechanisms, 
microorganisms growth and biofilm formation (Cremonini, 2016).  In this context, 
selenium nanoparticles (SeNPs) have shown to possess antibacterial, antiviral and 
antioxidant properties, suggesting they could be suitable as therapeutic candidates 
to combat infectious diseases. If compared to their counterparts, Selenite and 
Selenate, SeNPs are biocompatible and non-toxic and can be synthesized through 
different physical, chemical and biological methods (Wadhwani, 2016). In 
particular, nanostructured particles that can be synthesized using bacterial and 
fungal cells as biological catalysts, are gaining importance: biogenesis of 
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nanoparticles could be a non-toxic and eco-friendly process for the synthesis of 
novel antibacterial products (Zonaro, 2015).  
Selenium is a natural non-metallic element, occurring in four oxidation states: 
Selenate (Se
6+
), Selenite (Se
4+
), Selenite (Se
2−
), and elemental Selenium (Se
0
). Is 
essential in trace amounts for humans and animals but toxic at concentrations 
higher than the dietary doses. It is a key component of a variety of functional 
seleno-proteins in all living organisms, with the exception of higher plants and 
yeasts (Lampis, 2016). Some kind of microorganisms play a major role in the 
biogeochemical cycle of this element being able to tolerate selenium oxyanions 
using a Selenite/Selenate reduction mechanism. Depending on the species, the 
microbial reduction can occur through different mechanisms and can be the result 
of detoxification mechanism, a maintenance of the redox potential, or part of the 
respiratory electron transfer chain (Lampis, 2016).  
 
Mechanisms of microbial SeNPs synthesis 
Several microbial strains can reduce the toxic Selenite oxyanion to the less toxic 
elemental Selenium through the formation of Selenium nanoparticles (SeNPs), 
with a typical spherical shape and a diameter of 50-400 nm (Lampis, 2014). By 
definition, we can call nanoparticles, that particles having one dimension up to 
100 nm (Singh, 2015). 
The biogenic synthesis of these SeNPs can be extracellular, intracellular or 
bounded to the cell membrane. In a recent review, Wadhawani and collaborators 
(Wadhawani, 2016) give a detailed list of the different microbial and fungal 
species for whom synthesis of SeNPs has been reported. Gram-negative bacterial 
species as Pseudomonas spp., Agrobacterium spp. and E. coli, preferentially 
secrete the NPs via an extracellular mechanism. Stenotrophomonas spp., however, 
are able to use both extracellular and intracellular mechanisms. Among the Gram-
positive species, the synthesis of SeNPs has been reported for several Bacillus, 
and Lactobacillus species. Extracellular production of monodispersed SeNPs has 
been characterized in fungal strains of Aspergillus and plants (Wadhawani, 2016; 
Li, 2017). Recent studies showed the ability of Burkholderia fungorum strains to 
secrete Selenium nanoparticles, under aerobic conditions, as a consequence of an 
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intracellular reduction mechanism followed by a secretory process through cell 
lysis (Khoei, 2016). 
Due to the secretion process, the surface of biogenic SeNPs is surrounded by 
different chemical products, especially proteins, strongly related to NPs formation 
or metal reduction (Dobias, 2011). These proteins seems to be primarily 
implicated in the cell metabolism of fatty acid and carbohydrates. The binding 
ability of the proteins is also related to the spatial configuration and can control 
the size of the secreted NPs (Dobias, 2011). The “capping” agents are also 
important for their role in affecting the surface charge and NPs stability (Jain, 
2015). 
For both the two bacterial strains, Bacillus mycoides SeITE01 and 
Stenotrohomonas maltophilia SeITE02, used in this study and capable of 
producing SeNPs using an efficient Selenite reduction mechanism, a putative 
method for the biosynthesis of NPs has been addressed.  
The bacterial strain SeITE01 was firstly isolated from the rhizosphere of the 
Selenium hyperaccumulator legume Astragalus bisulcatus grown in Selenium 
contaminated soil. Its ability to induce the formation of amorphous Se
0
 
nanoparticles under aerobic conditions as a consequence of the reduction of 
Selenite was characterized, and the product of this reduction lead to an 
extracellular accumulation of Selenium nanoaprticles. The size of SeNPs is 
directly dependent on the incubation times: when the time of incubation is 
increased also the NPs size resulted increased.  In Fig.3 is reported a tentative 
explanation for the process of SeNPs formation given by Lampis and 
collaborators (Lampis, 2014). SeO3
2−
 ions could be reduced into Se
0
 by the 
simultaneous activity of enzymatic proteins, released by the bacterium, and 
sulfhydryl groups on thiols of peptides released by Bacillus cells. Also the  
membrane reductases may play a significant role in SeO3
2−
 reduction. Once 
reduced, Selenite ions are able to form Se nuclei which, subsequently, grow into 
the large SeNPs by further reductions  and aggregation of these Se atoms;  small 
SeNPs could stick together forming larger ones. As mentioned previously, 
SeITE01 cultures grown in the presence of Selenite, demonstrated the presence of 
spherical intracellular deposits of SeNPs by TEM analysis. The presence of a 
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bacillithiol reductase (BSH) system seems also to have a significant role the 
cytosolic thiol redox in Bacillus spp, concomitantly with the functions of other 
pathways (Fig.3B).  
 
Figure 3. Hypothesis of SeNPs formation in Bacillus mycoides SeITE01 has 
described by Lampis at al. (2014). 
 
The strain S. maltophilia SeITE02, as well, was isolated for the first time from the 
rhizosphere of Astragalus bisulcatus plant grown on polluted soil. This strain was  
proven to be highly resistant to SeO3
2−
 and capable of reducing it to elemental 
selenium under aerobic growth conditions with the consequent production  of  
SeNPs (Lampis, 2016). 
 The authors suggested that spherically shaped SeNPs could be observed mainly 
in the extracellular space, already after 13 h of incubation. In the same way of the 
strain B. mycoides SeITE01, the size of the secreted NPs is dependent on the time 
of incubation. It is worth noting that SeNPs of the same age displayed irregular 
dimensions. Observation using TEM analysis suggested that a releasing 
mechanism takes place in S. maltophilia SeITE02 after the initial formation of 
small nanoparticles within the cell. After the release of SeNPs, bacterial cells  
appeared damaged in their cell walls  and empty ghost cells were abundant and 
evident once the stationary phase was reached. 
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Through proteomic analysis, an alcohol dehydrogenase (AdH) homologue, was 
clearly identified and possibly associated with the biogenic synthesis of SeNPs. 
This result was confirmed by the identification of the gene encoding for alcohol 
dehydrogenase in the draft genome sequence of S. maltophilia SeITE02 
(Bertolini, 2014). This enzyme showed oxido-reductase activity and is involved in 
the metabolism of alcohols, it can work using both NADH and NADPH as 
electron donors and usually requires metallic cofactors. Basing on these results, a 
putative mechanism for Selenite biotransformation into SeNPs by S. maltophilia 
SeITE02, has been suggested. Inside the cells, a reduction of Selenite to elemental 
Selenium through reactions with thiol-containing molecules and/or 
peptides/proteins is carried out. Once formed, Se
0
 seeds are released to the 
extracellular space possibly by an already unknown export system, until they 
grow to form detectable SeNPs. An alcohol dehydrogenase homologue, was also 
identified and the authors concluded that this protein may play a role in SeNP 
synthesis and stabilization (Lampis, 2016). 
  
Antimicrobial and antibiofilm activities of Selenium nanoparticles 
Selenium-based nanomaterials have revealed interesting antimicrobial potential 
against a broad range of pathogenic strains, belonging both to Gram-positive and 
Gram-negative bacterial species. Tran et al., demonstrated that SeNPs produced 
using a simple colloidal synthesis method, are able to inhibit S. aureus growth 
already after 5 h of treatment and are also able to prevent S. aureus biofilm 
formation (Tran, 2011). In addition, SeNPs demonstrated a potent inhibiting 
activity against the growth of particularly challenging S. aureus methicillin-
resistant (MRSA) strains (Chihalova, 2015). 
Recent studies on biogenic SeNPs, demonstrated that these particle are effective 
against biofilms formed by different clinical bacterial isolates belonging to P. 
aeruginosa, S. aureus and Proteus mirabilis species (Shakibaie, 2014). A 
collection of more than 30 species isolated from different hospitalized patients 
was tested for the susceptibility to SeNPs biogenically produced by a Bacillus sp. 
strain. The results of this study showed that the NPs tested were good anti-biofilm 
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agents against the clinical isolates considered. Moreover, the study showed that 
different selenium oxidation states exhibits different effects on biofilms.   
Furthermore, biogenic SeNPs proved also capable of inhibit the proliferation of 
the promastigote and amastigote forms of Leishmania spp., in a dose dependant 
manner, and limit the localized cutaneous exacerbations in the animal model 
(Mahmoudvand, 2014; Beheshti, 2013).  
The antimicrobial activity of SeNPs against different yeast ad fungal strains 
(Shakibaie, 2015) has also been detected. Pathogenic fungi, as Asperigllus or 
Candida, are important human opportunistic pathogens, causing a spectrum of 
various lung infections, especially in immuno-compromised patients. In the last 
years, with the raise of resistant strains to current antifungal agents, the 
development of novel antimicrobial formulations is critical.  
 
Coating medical devices with SeNPs to prevent bacterial colonisation and biofilm 
formation 
Bacterial colonization and biofilm formation on medical devices is the primary 
cause for the spread of nosocomial infections, which primarily affects critically 
immuno-compromised patients. Try to prevent bacterial colonization on these 
devices by coating with a non toxic antimicrobial agent or bacterial adherence 
inhibitor, could be a possible alternative strategy.  
Different surfaces can be functionalized with Selenium NPs in order to prevent 
biofilm formation, as reported by Wang (Wang, 2012). Selenium-coated 
polycarbonate medical devices inhibit the growth of S. aureus biofilms on their 
surface if compared to non-coated devices. Biogenically synthesized SeNPs can 
ihibit S. aureus adherence and micro-colony formation on polystyrene, glass, and 
catheter coated-surface (Sonkusre, 2015). Moreover, paper towels covered with 
Selenium nanoparticles showed an high effectiveness against S. aureus, P. 
aeruginosa, E. coli, and S. epidermidis (Wang, 2015).  
 
Cytotoxicity and other possible applications for SeNPs 
Selenium nanoparticles have gained a great attention also as potential cancer 
therapeutic agents and drugs carriers, as well as they have shown excellent 
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antioxidant activity and disease prevention effects (Huang, 2013). He and 
collaborators (He, 2014) demonstrated that SeNPs are not toxic at supra-
nutritional levels in Sprague–Dawley rats and may be suitable as cancer 
chemoprevention agents. Different are the evidences that Selenium plays also a 
role in mammalian development, male reproduction, and immune function (He, 
2014). SeNPs can be internalized selectively by cancer cells through endocytosis 
and induce cell apoptosis by triggering apoptotic signal transduction pathways 
(Zhang, 2013). A variety of toxicology studies have been done to assess the 
SeNPs exposure effects on health. Toxic changes have been observed in fish and 
embryos exposed to nanoparticles, including oxidative stress-related changes such 
as lipid oxidation, apoptosis, changes in gene expression and non-specific 
oxidative stress (Chen, 2006; Nel, 2006).  
SeNPs demomstrated also able to reduce cell viability in human tumour lines as 
HeLa cells, in a dose-dependent manner (Ren, 2012). 
 
In this study we demonstrated how  microorganisms capable of transforming the 
toxic Selenium oxyanion into non-toxic elemental Selenium could be considered 
as biocatalysts for the production of nanomaterials (SeNPs), eventually 
exploitable in different biotechnological applications.  In such a context, an 
environmental beneficially process turned out to be a biocompatible product that 
efficiently  inhibit the growth of pathogens, including those resistant to 
antibacterial drugs. 
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4. MATERIALS AND METHODS 
 
4.1 PREPARATION AND CHARACTERIZATION OF SELENIUM 
NANOPARTICLES 
Preparation of Biogenic Selenium Nanoparticles (SeNPs) 
 Biogenic SeNPs were produced by exploiting the selenite reduction capability of 
two different environmental bacterial isolates. Stenotrophomonas maltophilia 
SeITE02 and  Bacillus mycoides SeITE01 were used to produce respectively Sm-
SeNPs(-) and Bm-SeNPs(+) (Lampis, 2014; Santi, 2013; Di Gregorio, 2005). 
Sterile nutrient broth supplemented with 2 mM Na2SeO
3
 was inoculated to 
achieve final concentrations of 10
5
 and 10
7
 CFU/ml for B. mycoides SeITE01 and 
S. maltophilia SeITE02 respectively. The cultures were incubated aerobically at 
27°C in a rotary shaker (150 rpm) for 6 h (B. mycoides SeITE01) or 24 h (S. 
maltophilia SeITE02). Bacterial cells and nanoparticles were removed from the 
culture medium by centrifugation at 10000 g for 10 min. The pellets were washed 
twice with 0.9% NaCl, suspended in Tris/HCl buffer (pH 8.2) and the cells were 
disrupted by ultrasonication at 100 W for 5 min. The suspension was then 
centrifuged at 10000 g for 30 min to separate disrupted cells (pellet) from 
nanoparticles (supernatant). The nanoparticles were recovered after centrifugation 
at 40000 g for 30 min, washed twice and suspended in deionized sterile water. Ch-
SeNPs were produced as described by Lin (Lin, 2005).  
 
 Cell free extracts and CFX-SeNPs preparation  
Stenotrophomonas maltophilia SeITE02 and B. mycoides SeITE01 cells were 
grown for 24 h until stationary phase. They were then centrifuged at 3000 g for 15 
min and washed twice with phosphate buffer saline. The pellet was resuspended 
in 100 mM Tris–HCl pH 7.4 and sonicated at 100 W five times for 5 min. Finally, 
unbroken cells were separated by centrifugation at 16000 g for 30 min and the 
supernatant was recovered. CFX-SeNPs were then prepared by exposing Ch- 
SeNPs to CFX of S. maltophilia SeITE02 or B. mycoides SeITE01 overnight in 
agitation. CFX-SeNPs were recovered through centrifugation and washed twice 
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with 100 mM Tris–HCl pH 7.4, as described by Dobias and coworkers (Dobias, 
2011).  
 
Scanning electron microscopy (SEM) 
Both the biogenic and synthetic SeNPs were analysed by Scanning Electron 
Microscopy (SEM). The nanoparticles were fixed, dehydrated through an 
increasing ethanol concentration series and dried in liquid CO2 using the critical 
point method. The particles were mounted on metallic specimen stubs and directly 
observed using an XL30 ESEM (FEI, Hillsboro,OR, USA) equipped with an 
EDAX micro-analytical system, which was used to determine the elemental 
composition of the analysed nanoparticles.  
 
Dynamic Light Scattering (DLS) Analysis  
Measurements of Dynamic Light Scattering (DLS) from dispersed nanoparticles 
were made in Nanoscience Lab at University of Calgary (Canada). Data were 
measured using a Zeta sizer Nano-ZS by Malvern instrument with He-Ne laser at 
the wave length of 633 nm and a power of 4.0m was a light source collecting data 
at a fixed scattering angle of 173◦. 300μL of the sample was applied to a quartz 
cell with a 10mm path length and data collected at 25◦C. From the auto 
correlation function, the relaxation rate, Ŵ, is determined allowing for the 
translational diffusion coefficient, D, to be calculated using D = Ŵ/Q2, where Q 
in the magnitude of the scattering vecto r[Q = (4pn/l) sin "; n is the refractive 
index of the solution, l the wave length of the scattered light ,and " the scattering 
angle].The viscosity of the water was taken as 8.9 × 10
−4
 Pas and its refractive 
index as 1.33 at 25°C. The diffusion coefficient so f the dispersed particles can be 
determined from the intensity of the autocorrelation function. Hydrodynamic 
diameter, Dh, can then be calculated from the diffusion coefficients, D, by using 
the Stokes-Einstein relation [Dh = (KBT)/3p!D;where KBT in thermal energy and 
! is the viscosity of the dispersion medium]. Our analysis used a cumulant fit to 
the correlation function and gives the averaged weight ed diameter and a 
polydisperity index (PDI). A regularized fit to the DLS data gives more details on 
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the size distribution of the dispersed nanoparticles. All the values were obtained 
using the software provided by the Malvern with the instrument.  
 
Quantification of proteins and carbohydrates still remaining on the NPs surface 
after different denaturing treatment 
Biogenic SeNPs were collected through centrifugation at 16000 rpm and 
subsequently exposed to three different treatments: (1) 10% SDS; (2) 10% SDS 
and boiling for 10 min; (3) 10% SDS and boiling for 30 min (Dobias, 2011). 
SeNPs were then centrifuged at 16000 rpm and the supernatants was separated in 
order to quantify proteins and carbohydrates content obtained after different 
treatments.  
Protein concentration was determined using the method of Lowry et al. (Lowry, 
1951) using bovine serum albumin (BSA) as standard; carbohydrates were 
measured using the anthrone method (Roe, 1955) using glucose as standard.  
SeNPs obtained after different treatments were characterized using Dynamic Light 
Scattering (DLS) analysis. DLS was carried out using a Zen 3600 Zetasizer Nano 
ZS (Malvern Instruments, Malvern, UK) equipped with a 633 nm helium-neon 
laser light source (4.0 mW), detecting scattering information at a fixed angle of 
173°. SeNPs samples (300 µl) were transferred to a quartz cuvette (10 mm path 
length), and the mean size distribution and zeta potential were recorded at 25°C 
using the software provided by Malvern Instruments.  
 
4.2 ANTIMICROBIAL AND ANTIBIOIFLM ACTIVITY OF SELENIUM 
NANOPARTICLES 
 Growth conditions and Microbial strains 
Tryptic Soy Broth (TSB, Oxoid, Basingstoke, England), a highly nutritious 
general medium was used for the growth of bacteria. 
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Formula gm/liter 
Pancreatic digest of casein 17.0 
Enzymatic digest of soya bean 3.0 
Sodium chloride 5.0 
Dipotassium hydrogen phosphate 2.5 
Glucose 2.5 
 
Sabouraud Liquid Medium (Oxoid), a liquid medium recommended for sterility 
testing, for non-sterile testing and for the determination of the fungistatic activity 
of pharmaceutical products was used for the growth of fungal strains. 
 
Formula gm/liter 
Pancreatic digest of casein 17.0 
Enzymatic digest of soya bean 3.0 
Sodium chloride 5.0 
Dipotassium hydrogen phosphate 2.5 
Glucose 2.5 
 
Different bacterial strains belongings to different bacterial species representative 
of both Gram-negative and Gram-positive were considered in this study (Tab.1). 
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Table 1. List of the different bacterial strains considered in the study and their 
origin. 
 
 
 
Bacterial species Strain Name Origin 
Pseudomonas aeruginosa PAO1 Ref strain 
P. aeruginosa ATCC27853 Ref strain 
P. aeruginosa INT Urine sample (MDR) 
P. aeruginosa BR1 Broncoalveolar lavage 
P. aeruginosa BR2 CF patient sputum 
P. aeruginosa CFC20 CF patient sputum 
P. aeruginosa CFC21 CF patient sputum 
P. aeruginosa CFCA CF patient sputum 
P. aeruginosa CFCB CF patient sputum 
P. aeruginosa FUS1 Burn wound 
P. aeruginosa TN1 Nasal swab 
Stenotrophomonas  maltophilia VR10 Broncoalveolar lavage 
S. maltophilia VR20 Broncoalveolar lavage 
Achromobacter xylosoxidans C CF patient sputum 
Burkholderia cenocepacia LMG16656 CF patient sputum 
Acinetobacter baumanii LMG 10531 wound infection 
Staphylococcus aureus Mu50 Ref strain (MDR) 
S. aureus UR1 Urine sample 
S. haemolyticus UST1 Burn wound 
S. epidermidis ET024 Endotracheal tube 
Propionibacterium acnes LMG 16711 Human facial acne 
Candida albicans CVr-21 Vaginal swab 
C. albicans SC5314 Reference strain 
C. parapsilosis CP-Vr5 Vaginal swab 
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 Determination of the minimum inhibitory concentration (MIC) of biogenic NPs 
The susceptibility of each strain to different types of SeNPs were determined in 
triplicate according to the Clinical and Laboratory Standard Institute (CLSI, 2016) 
protocol using broth microdilution method in ﬂat-bottom 96 well microtiter plates. 
The microbial inoculum was standardized to approximately 10
5
 CFU/ml. Plates 
were incubated at 37°C for 24 h and the optical density (O.D.) at 590 nm was 
determined using a multilabel microtiter plate reader (Envision, Perkin-Elmer 
LAS, Waltham,  MA). The MIC was recorded as the lowest SeNPs concentration 
at which  no significant O.D. increase was observed. 
 
Biofilm formation assay 
Bacterial cells were grown at 37 °C in TSB-1% glucose  and yeast cells were 
grown in Sabouraud medium until they reached the exponentially growing phase 
(OD650nm=0.4). Exponentially growing cells were then diluted in culture medium 
to reach approximately 10
6 
CFU/ml. Two hundred microliter of each cell 
suspension were used to inoculate sterile flat-bottomed polystyrene 96-well 
microtiter plates (MTP) (CytoOne, Starlab). As a negative control, 200 µl of the 
medium without any bacterium were added to the related well and plates were 
incubated aerobically at 37°C without agitation for 24 h to allow biofilm 
formation. After incubation, the planctonic cells were aseptically aspirated and 
washed with sterile physiological saline solution (PS). The biofilm formed was 
quantified adding 100 µl of 1% methylene blue staining to each well for 15 
minutes at room temperature. Each well was then slowly washed once with sterile 
water and dried at 37 °C. The methylene blue bound to the biofilm was extract 
using 100 µl of  70% ethanol and the absorbance measured at 570 nm using “A3 
Plate Reader” microplate reader (DAS srl, Italy). All experiments were performed 
in triplicate. Optical densities greater than 2, between 1 and 2 or between 0.5 and 
1 optical units were considered to correspond to strong (S), medium (M) or low 
(L) biofilm production respectively. 
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Biofilm inhibition and disintegration assay for biogenic SeNPs. 
In order to evaluate the anti-biofilm effect of SeNPs the bacterial strains were 
separately inoculated into 96-well microplates as previously described. SeNPs 
were diluted in TSB-1% glucose or Sabouraud medium to reach the concentration 
of 50-500 µg/mL and added to the wells. After 24 h incubation at 37 °C, the 
biofilm formation was quantified with methylene blue and the absorbance 
measured at 570 nm, as previously described.  
In order to evaluate the biofilm disaggregating effect of SeNPs the bacterial 
strains were plated into 96-well MTPs and incubated for 24 h at 37 °C to allow 
biofilm formation. After incubation the medium was aseptically aspirated. SeNPs 
were diluted in medium to reach the concentration of 50-500 µg/mL and added to 
the wells. The microplates were then incubated for additionally 24 h at 37 °C and 
the amount of biofilm was quantified as previously described. All the mentioned 
experiment were performed in triplicate. 
 
Biofilm formation and treatment with different types of SeNPs 
A series of polystyrene round-bottomed 96-well microtiter plates were inoculated 
with 100 µl of a bacterial culture containing approximately 5x10
7
 CFU/ml and 
incubated at 37°C for 4 h. The  bioﬁlms formed were rinsed once with 100 µl of  
physiological saline solution (PS) to remove all non-adherent cells and 
subsequently treated with 128 µg/ml of the four different kinds of SeNPs diluted 
in PS. For every strain, untreated biofilms were included as control. Then, 100 µl 
of fresh medium was added to each well and the plates were incubated for 
additional 20  hours at 37°C.  
 
Quantification of the biofilm biomass (Crystal Violet assay, CV assay) 
The biofilms obtained after treatment, were rinsed with 100 µl PS and were fixed 
to plates by addition of 100 μl 99% methanol. After an incubation of 15 min at 
room temperature, the supernatant was removed and the plates were air dried. 
Then, 100 μl of a 0.1% CV solution was added to each well (20 min incubation at 
room temperature). The excess of CV was removed by washing the plates under 
running tap water. Finally, 150 μl of 33% acetic acid was added in order to release 
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the CV bounded to the biofilms and the plate was put on a vortex for at least 20 
minutes (800 rpm). The absorbance was then measured at 590 nm. The 
experiments were performed in triplicate (Peeters, 2007).  
 
Quantification of surviving cells  
After biofilm formation and treatment as reported above, bacteria included in the 
biofilm were collected by two cycles of sonication and vortexing. The cell pellet 
obtained after centrifugation (5 min at 13000 rpm) was resuspended in 1 ml of PS 
and the number of colony forming units (CFU) was determined by plating on TSA 
Tryptone Soy Agar, Oxoid). Three biological replicates were included (Peeters, 
2007). 
 
Reactive Oxygen Species production assay (ROS assays) 
ROS production by bacterial cultures after treatment with biogenic nanoparticles 
was investigated. The concentration of  NPs used  was corresponding to the MIC 
for all strains considered, except for S. aureus Mu50 (the concentration of  NPs 
applied was corresponding to 50% of growth inhibition). Overnight cultures of 
every strain were dispensed in four tubes and 2′-7′- dichlorodihydrofluorescein 
diacetat  (H2DCF-DA, Sigma-Aldrich, Bornem, Belgium) was added to a couple 
of tubes at a final concentration of 10 µM. All tubes were incubated for 1 hour at 
37°C and  then centrifuged for 5 min at 13000 rpm.  Biogenic NPs was added to 
two aliquot of cells (one with H2DCF-DA and one without). Appropriate controls 
to which an equal volume of PS was added instead of NPs were also included. All 
cell suspensions were transferred to a black microtiter plate. Six wells were filled 
per condition. The fluorescence (λex= 485 nm and λem=535 nm) was measured 
every 30 min for approximately 24 hours  with microtiter plate reader (Perkin-
Elmer LAS). The net fluorescence emission by the NPs-treated and the untreated 
cells (control) was calculated and a corresponding graph was constructed. The 
results are only comparable within a plate and not between different plates (Wang, 
1999). All experiments were repeated at least three times. 
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4.3 EVALUATION OF THE SYNERGIC EFFECT OF BIOGENIC SeNPs 
AND ANTIBIOTICS 
Microbial strains and growth conditions 
Experiments were conducted using representative of both reference strains and 
clinical isolates. Specifically, we analyzed two strains of Pseudomonas 
aeruginosa, namely P. aeruginosa PAO1 (reference strain), INT (MDR clinical 
isolate) and two clinical strains of Staphylococcus aureus: Mu50 strain (reference 
strain, methicillin resistant and intermediate vancomycin resistant) and a clinical 
strain isolated from an urine sample (S. aureus UR1). All bacterial strains were 
grown in TSB medium at 37°C.   
 
Drugs and antibiotics used 
Clarithromycin (Klacid) (Abbott, BGP Products S.r.l. Roma, Italy) 
Levofloxacin (Glaxo Wellcome S.p.A., Verona, Italy) 
Oxacillin (Sigma-Aldrich, St. Louis, USA) 
Trimethoprim/Sulfamethoxazole (Bactrim) (Roche, Basel, Swizerland) 
Tobramycin (Sigma-Aldrich, St. Louis, USA) 
Vancomycin (Abbott, BGP Products S.r.l. Roma, Italy) 
 
Determination of minimum inhibitory concentration and fractional inhibitory 
concentration (FIC)  
To evaluate the antibacterial activity of SeNPs in combination with antibiotics, a 
two-dimensional microdilution assay was used (Wan, 2016). Assays were carried 
out in TSB growth medium. Minimum inhibitory concentration (MIC) for each of  
the antibiotics (Clarithromycin, Levofloxacin, Oxacillin, Trimethoprim/ 
Sulfametoxazole, Tobramicin and Vancomycin) and nanoparticles was first 
estimated according to the Clinical and Laboratory Standard Institute (CLSI, 
2016) protocol using the broth microdilution method in ﬂat-bottom 96 well MTP. 
The fractional inhibitory concentration index (FICI) of a combination of 
antibiotics and SeNPs was subsequently determined by the checkerboard method. 
The antibiotic of the combination was serially diluted along the abscissa, while  
the SeNPs were diluted along the ordinata. An inoculum of approximately 10
5
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CFU/ml was prepared from each strain. Each MTP well was inoculated with 100 
µl of the bacterial suspension, and the plates incubated at 37°C for 24 h under 
aerobic conditions. The results were assayed by measuring the optical density 
(OD)600. The combined antimicrobial effect of agents A and B (where A is one of 
the antibiotics and B SeNPs) was calculated as follows:  
 
               MIC (A in combination with B)             MIC (B in combination with A) 
FICI =                                                        +  
                          MIC (A alone)                                          MIC (B alone) 
 
The combination is considered synergistic when the FICI is ≤ 0.5, partially 
synergistic when the FICI is > 0.5 to ≤ 1, additive when the FICI is > 1 to < 4, and 
antagonistic when the FICI is > 4 (Odds, 2003). 
 
Biofilm formation and treatment with combination of SeNPs and antibiotic 
A series of polystyrene round-bottomed 96-well microtiter plates were inoculated 
with 100 µl of a bacterial culture containing approximately 5 X 10
7
 CFU/ml and 
incubated at 37°C for 4 h. The bioﬁlms formed were rinsed once with 100 µl of  
physiological saline solution (PS) to remove all non-adherent cells. 100 µl of fresh 
TSB medium were added to each well and the plates were incubated for further 
24h. After incubation at 37°C, mature biofilms were treated with different 
concentration of SeNPs alone or in combination with the different antibiotics, 
diluted in PS. For every strain, no treated biofilms (six wells) will be included as a 
control.  
 
Quantification of cells 
After incubation at 37°C for 24 hours, the bioﬁlms were rinsed with PS to remove 
sessile cells. The number of CFU/ml still present in biofilms were determined by 
conventional plating as previously described.  
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Quantification of the biofilm biomass (Crystal Violet assay, CV assay) 
After 24 hours of incubation, the biofilms were rinsed with 100 µl PS and fixed to 
the bottom of the well by addition of  100 μl 99% methanol. Biofilms biomass 
after treatment was determined by CV staining as previously described and the 
results compared to a non treated control.  
 
4.4 CHRONIC IN VITRO WOUND MODEL  
Artificial derimis (AD) were prepared as described by Backman et al 2016. The 
protocol is composed of different subsequent steps with the final aim to form an 
artificial substrate composed of an upper layer and a lower layer able to recreate 
the real conditions that can be found in chronic wound and soft tissue infections 
having a surface consisting of hyaluronic acid and collagen. 
Day 1 (first layer) 
The upper layer is a chemically cross-linked hyaluronic acid (HA) spongy sheet. 
An high-molecular weight (HMW) solution of sodium hyaluronate powder (1.20–
1.80 MDA; Lifecore Biomedical, MN, US) was prepared in sterile distilled water 
(DW) (1.5%, pH 6.8). Then the HMW-HA solution was adjusted to pH 3.5 adding 
some drops of a HCl solution. As a cross-linking agent for HA molecules, was 
used ethylene glycol diglycidyl ether (EX810; Sigma-Aldrich, Bornem, Belgium): 
an aqueous solution of EX810 with a weight ratio HA:EX810 of 5:1, was added to 
the HMW-HA solution with vigorous stirring. One ml of this mixed solution was 
finally poured into a freeze-drying container, stored at 4 °C overnight followed by 
freezing at -80°C and then an overnight freeze-drying.  
 
Day 2 (second layer) 
The lower layer is a spongy sheet composed of HA and collagen (Col). HA 
powder was dissolved in DW to have a 1% HMW-HA solution (pH 6.8). 
Separately, a second HA 1% solution was autoclaved at 120 °C for 30 min to 
obtain a partially hydrolyzed low-molecular-weight HA (LMW-HA) solution. A 
0.1% collagen solution was warmed at 50 °C for 10 min to obtain a heat-
denaturated collagen solution. The three above-mentioned solutions were then 
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mixed together and adjusted to pH 7.5 with NaOH. One milliliter of this final 
solution was poured into the freeze-drying container into which the first spongy 
sheet layer was prepared. The combined product was stored at 4 °C overnight 
followed by freezing at −80 °C and then freeze-drying to obtain a two-layered 
spongy sheet.  
Finally, the artificial dermis (AD) obtained were taken off by the container by 
braking the glass. Both sides were irradiated with a UV lamp for 20 min to cross-
link the collagen molecules. This spongy sheet was then sterilized in an oven at 
110 °C for 1 h to obtain a sterile AD of approximately 1 cm × 1 cm (height × 
width). 
 
Set up of the infection protocol 
To evaluate the inhibiting and eradicating activity of SeNPs, biofilms were grown 
on AD as previously described by Brackman et al (Brackman, 2011). The medium 
used for the experiments was prepared dissolving fresh plasma in sterile Bolton 
Broth (Sigma-Aldrich) and adding freeze–thaw laked horse blood at a final 
concentration of 5%.  
 
Formula gm/liter 
Enzymatic digest of animal tissues 10.0 
α-ketoglutaric acid 1.0 
Lactalbumin hydrolysates 5.0 
Sodium carbonate 0.6 
Sodium Chloride 5.0 
 
The ADs were placed in 24-well microtiter plate (TPP) and 500 μl of the medium 
were added, and was entirely taken up by the sponge layer. Five hundred 
microliters of the medium were then added around the AD to avoid dehydration 
during the experiment. An overnight culture of the strains to test was resuspended 
in physiological saline and diluted to 10
6 
CFU/mL. Each AD was inoculated with 
10 μl of the cell suspension. To evaluate inhibition of biofilm formation, 100 μl of 
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SeNPs were spread on the surface of each AD immediately after inoculation. 
Sterile PS was added to the controls. After 24 h at 37°C biofilms were rinsed once 
with PS and the number of culturable cells (CFU) present in the biofilms were 
collected by placing the AD into tubes containing 10 mL PS. After three cycles of 
vortexing (30 s) and sonication (30 s; Branson 3510; Branson Ultrasonics Corp., 
Danbury, CT) the resulting suspension was serially diluted and plated in TSA 
medium. 
To determine the biofilm eradicating activity, the plate with the ADs was 
incubated for 24 h at 37 °C to allow biofilm formation. After incubation, the 
medium was removed, the biofilms were washed with PS, fresh medium was 
added and 100 μl of SeNPs were dropped on top of the biofilm. Plates were 
incubated at 37 °C for additional 24 h. Subsequently, biofilms were rinsed once 
with PS and the cells still present were collected by previously described. The 
number of CFU/ml was determined by conventional plating. A minimum of three 
samples both for the control and treatment with SeNPs was analyzed and this was 
repeated on at least two separate days. 
 
Determination of the minimum inhibitory concentration (MIC) of biogenic NPs 
The susceptibility of each strain to used to infect the dermis to Sm-SeNPs was 
determined in triplicate according to the Clinical and Laboratory Standard 
Institute (CLSI, 2016) protocol using the broth microdilution method in ﬂat-
bottom 96 well microtiter plates, as previously described. TSB was used as 
growing medium and fresh plasma was dissolved in it. MICs obtained with this 
method were then compared to the ones obtained using TSB medium alone.  
 
 
4.5 FLOW CELLS GROWTH MODEL  
Biofilms were grown in continuous flow culture chambers (flow cells), 
constructed as described by Pamp et al. (Pamp, 2008). A conventional microscope 
glass slide and a coverslip as the bottom and upper part of the chamber 
respectively, were fixed by a silicon sheet to a polycarbonate aluminium flow 
cells and were used to form the two separate rectangular channels. TSB medium 
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diluted 8 times was used as growth medium and connected through silicon tubes 
to the flow cell. A bubble trap was mounted between the two to avoid bubble 
formation. The system was filled with medium using a peristaltic pump (Watson 
Marlow, Calmouth, Cornwall, England) with a consistent flow rate of 0.2 ml/min. 
An effluent reservoir was then placed at the most downstream part of the system 
(Fig.4). 
An overnight culture of P. aeruginosa PAO1 and INT strain, grown in TSB 
medium at 37°C, was used to prepare an inoculum of 0.05 OD at 590nm. The 
continuous flow was stopped and each channels, one for the control and one for 
the treatment, was independently inoculated with 5 ml of bacterial suspension. 
The flow cells were then incubated for 1 h to allow attachment of the bacterial 
cells to the substratum and then the flow was restarted. After 3 days of incubation 
at 37°C, the continuous flow of fresh medium was stopped, the tubes connected to 
the chamber corresponding to the treatment clamped, and the bottle of medium 
substituted with one containing fresh medium supplemented with selenium 
nanoparticles at a final concentration of 128 μg/ml. The flow was then restarted 
and the mature biofilm was exposed to the SeNPs treatment for 24 hours. Some 
drops of the effluent from the flow cells were aseptically collected during the 
treatment at the time zero (immediately after that the flow was restarted) then after 
1, 4, 24 hours of treatment and the number of CFU/ml was determined by 
conventional plating in TSA medium (Oxoid) and compared to a non treated 
control collected at the same times.  
 
 
 
 
 
 
 
Figure 4. Schematic representation of the flow cells system. 
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Quantification of cells in biofilms 
After 24 h of treatment with continuous flow at room temperature, coverslips 
were aseptically removed from the flow cells, and the cells in biofilms collected 
by adding 1 ml of PS on the surface of the glass and scratching with a sterile cell 
scraper. The bacterial suspension was then serially diluted in PS and the number 
of CFU/ml still present in the biofilm determined by conventional planting in TSA 
medium and compared to a non treated control. 
 
 
4.6 CAENORHABDITIS ELEGANS: A SIMPLE “IN VIVO” MODEL 
Caenorhabditis elegans strain N2 ∆glp-4 ∆sek-1 was used and worms were grown 
as previously described by Vandecandelaere et al (2017). This strain is incapable 
of producing progeny at 25 °C (∆glp-4) (Beanan, 1992) and exhibits an enhanced 
sensitivity to various pathogens (∆sek-1) (Kim, 2002).  
Preparation of Nematode Growth Medium (NGM) plates 
Nematodes were grown on Nematode Growth Medium (NGM) agar which has 
been prepared adding 3 g NaCl, 17g Agar, 2.5 g peptone to 975 ml H2O. The 
solution was then autoclaved and once cooled down, 1 ml CaCl2 1M, 1 ml 
cholesterol (5mg/ml in ethanol), 1 ml MgSO4 1M and 25 ml KPO4 1M were 
added. The medium has been then aseptically poured into Petri dishes. Before use 
the plates were leaved 2-3 days at room temperature to allow detection of 
contaminants and to allow excess moisture to evaporate. 
 
Preparation of bacterial food source (E. coli OP50)  
Briefly, a single colony of E. coli OP50 was aseptically inoculate in TSB broth 
and incubated overnight at 37°C. Using an inoculating loop approximately 100 µl 
of the O/N suspension were spread on NGM agar plates and incubated at 37°C for 
6 h to allow the formation of a thin bacterial layer. The worms tend to spend most 
of the time in bacteria and these plates can be used to keep the C. elegans 
nematodes in culture.  
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Transferring the worms (“chunking” technique) 
This technique was used to transfer C. elegans from one petri plate to another. A 
stainless steel spatula was sterilized by holding it on the flame and cooled down in 
sterile MilliQ water. An NGM plate containing nematodes was cut approximately 
in 1 cm
2
 pieces and 1-3 pieces were transferred to another NGM plate with an E. 
coli OP50 lawn. The warms will crawl out of the chunk and spread out onto the 
bacterial lawn on the plate. The plates was stored at 15°C for 2 weeks for 
culturing. 
 
Obtaining a synchronised C. elegans population (“bleaching”) 
The plates containing C. elegans were washed with sterile PS and collected in a 
falcon tube. The nematodes were let sink down and washed another times. Warms 
were then bleached by adding 1 mL 5% sodium hypochlorite (Sigma) and 0.5 mL 
4 M NaOH (Sigma) and by vortexing for 10 sec every 2 minutes for a total of 10 
minutes. The resulting eggs were incubated for 3–4 days at 25 °C on NGM 
medium plates previously precultured with E.coli OP50 strain, to obtain L4 stage 
worms (Brenner, 1974).  
 
C. elegans infection assay 
In a 24-well flat-bottomed microtiter plate, approximately 30 L4 stage worms 
were added per well in growth medium containing 95% M9 buffer (3 g KH2PO4, 
6 g Na2HPO4, 1 ml 1 M MgSO4 per litre), 5% Brain Heart Infusion broth (Difco 
Laboratories, Detroit, MI, USA) and 0.1 v/v % of a 5 mg/ml cholesterol solution 
(Sigma). Worms were infected by adding 25 µl of a bacterial cell suspension (10
7
-
10
8
 CFU/mL). The effect of different dilutions of SeNPs on infected C. elegans 
was evaluated and compared to the same number of wells treated with PS as a 
negative control. The total volume per well was 1 mL. The plates were incubated 
at 25 °C and scored for live and dead worms every 24 h (up to 48 h). Worms were 
considered dead if they were straightened and if no movement was observed. 
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4.7 FLUORESCENCE MICROSCOPY 
Live/Dead staining (Life Technologies) was prepared adding to 994 μl of PS, 6 μl 
of Syto9 and propidium iodide (PI). Some drops of the staining were then added 
on the biofilm formed on the glass slide. After an incubation period of 15 minutes,  
the staining was removed and some drops of PS were added to avoid biofilm 
drying, a coverslip was then mounted on the slides and the glasses were observed 
at fluorescence microscope (Evos FL Auto, Life Technologies). 
The commercial kit used for the assay is composed by two different nucleic acid 
stains that can allow to rapidly distinguish live bacteria with intact plasma 
membranes from dead bacteria with compromised membranes. Indeed cellular 
and membrane integrity is considered to be one criterion distinguishing between 
dead and viable bacterial cells. These last ones are assumed to have intact and 
tight cell membranes that cannot be penetrated by some staining compounds, 
whereas dead cells are considered to have disrupted and/or broken membranes. 
The red-fluorescent nucleic acid stain Propidium Iodide (PI) intercalates to DNA 
with no sequence preference with one dye molecule per four to five base pairs, 
identifying dead cells in the bacterial population stained. PI is not permeable 
through bacterial membranes and is usually excluded by living cells. On the 
contrary, the green-fluorescent nucleic acid stain SYTO9 is a membrane-
impermeable-dye that can enter both live and dead bacterial cells. When both dyes 
are present, PI exhibits a stronger affinity for nucleic acids than SYTO9, and 
hence, SYTO9 is displaced by PI (Pamp, 2008). 
 
 
4.8 SeNPs TOXICITY IN AN “IN VIVO” MOUSE MODEL 
Animals were maintained under conventional housing conditions and 
acclimatized for at least 5 days before the experiment to the local animal facility 
conditions (room temperature: 20–24°C; relative humidity: 40–70%), having free 
access to standard rat chow and tap water. The experiments were conducted 
according to the Principles of Animal Care (publication no. 85–23, revised 1985) 
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of the National Institutes of Health and with the current law of the European 
Union and Italy (D. L.vo 116/92).   
Female congenic C57BL/6J WT and gut-corrected CFTR
tm1UNC 
(8-10 weeks old) 
mice were purchased from Cystic Fibrosis animal Core facility (San Raffaele 
Hospital, Milan, Italy). Prior to use, animals were acclimatized for at least 5-7 
days to the local vivarium conditions, having free access to standard rodent chow 
and tap water. 
 
Intratracheal challenge of Sm-SeNPs(-) 
Mice were anesthetized with 2.5% isofluorane and placed on an intubation 
platform hanging by their incisor teeth. After visualization of the opening of the 
trachea using a laryngoscope, SeNPs solution at different concentrations were 
instilled by an intubation tube connected to a pressure control system. The 
animals were observed for viability and clinical signs of toxicity on the day of 
dosing (after 3 h) and then daily up to 5 days. In a similar trial, the negative 
control group received 0.9% apyrogenic sterile NaCl.  
 
 
4.9 EVALUATION OF SeNPs CYTOTOXIC EFFECT IN HUMAN CELL 
CULTURES 
Preparation and culture of dendritic cells and fibroblasts  
After written informed consent was received from donors, and approval by the 
Ethical Committee (Prot. no. 5626, February 2nd 2012, and Prot. no. 43318, 
September 4
th
 2013), buffy coats from the venous blood of normal healthy 
volunteers were obtained from the Blood Transfusion Centre at the University 
Hospital of  Verona. Peripheral blood mononuclear cells were isolated by Ficoll-
Hypaque and Percoll density gradient centrifugation (GE Healthcare Life 
Sciences, Little Chalfont, UK) and used for the immunomagnetic isolation 
(Miltenyi Biotec) of CD14+ cells as previously described (Zenaro, 2009). DCs 
were isolated by incubating 1x10
6
 monocytes per ml at 37°C in 5% CO2 for 5–6 
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days in six-well tissue culture plates (Greiner Bio-One, Nurtingen, Germany) in 
RPMI 1640 medium supplemented with heat-inactivated 10% low-endotoxin 
FBS, 2 mM L-glutamine, 50 ng/ml GM-CSF and 20 ng/ml IL-4. The final DC 
population was 98% CD1a+, as measured by FACS analysis.  
Human primary fibroblast CCD1112Sk cells (ATCC®CRL-2429) were purchased 
from ATCC (Manassas, VA, USA) and cultured in DMEM supplemented with 
10% heat-inactivated FBS plus 2 mM L-glutamine at 37°C in 5% CO2.  
 
Quantification of cytokine production  
Cytokine production in cell culture supernatants was determined by ELISA using 
Ready-Set-Go ELISA kits (eBioscience, San Diego, CA, USA) according to the 
manufacturer’s instructions. We measured the levels of IL-12 (range 4–500 
pg/ml), TNF-α (range 4–500 pg/ml) and IL-6 (range 2–200 pg/ml). The ELISA 
development kit (Mabtech, Nacka Strand, Sweden) was used to determine the 
level of IL-8 (CXCL8 range 4–400 pg/ml). Briefly, DCs were treated with 
different concentrations of  SeNPs for 24 h, and then the supernatants were 
collected. DCs were also activated with 100 ng/ml LPS as a positive control. The 
plates were read at 450 nm with Victor3 1420 Multilabel Counter (Perkin Elmer, 
Waltham, MA, USA).  
 
Cell viability evaluation  
Cell viability was assessed using the AlamarBlue assay (Invitrogen, Thermo 
Fischer Scientific, Waltham, MA, USA) according to the manufacturer’s 
instructions. After incubation for 24 h with SeNPs, the reagent was added to the 
culture medium a final concentration of 10% before measuring the absorbance at 
570 and 600 nm.  
 
 
4.10 STATISTICAL ANALYSIS 
All the data are expressed as means plus Standard Error Mean (SEM) or Standard 
Deviation (SD). Statistical analyses, including t-Test and One-Way and Two-Way 
analysis of variance (ANOVA), was performed using GraphPad Prism 6.0 
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(GraphPad Software Inc., La Jolla, CA, USA). The level of significance was set at 
P value < 0.05. 
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5. RESULTS
 
5.1 BIOGENIC SELENIUM NANOPARTICLES: CHARACTERIZATION, 
ANTIMICROBIAL AND ANTIBIOFILM ACTIVITY 
Biogenic SeNPs were produced by exploiting the selenite reduction capability of 
Bacillus mycoides SeITE01 and Stenotrophomonas maltophilia SeITE02, two 
different environmental bacterial isolates. The biogenic SeNPs were compared 
with synthetic Ch-SeNPs in terms of their physicochemical characteristics: as 
indicated by scanning electron microscopy (SEM) analysis, all the three types of 
nanoparticles were spherical. EDAX microanalysis of the purified SeNPs revealed 
the characteristic selenium absorption peaks at 1.37 (SeLα), 11.22 (SeKα) and 
12.49 keV (SeKβ) (Fig. 5). However, SeNPs differently synthesized showed 
different elemental composition (Tab.2): the ones synthesized by Sm-SeNPs(-) 
showed a selenium percentage in weight of 11.01% and Bm-SeNPs (+) a selenium 
percentage of 9.26. On the other hand, Ch-SeNPs exhibited a higher percentage in 
selenium, 31.61%. Furthermore, the composition of biogenic SeNPs, showed that 
they were rich in C, O, P and S, this suggesting the presence of biological 
macromolecules surrounding the nanomaterials. It is possible to hypothesize that 
this biogenic SeNPs cap include proteins, membrane phospholipids (P peaks) and 
also some cellular residues. 
A possible composition and characterization of the biomolecular capping 
surrounding SeNPs biosynthesized by S. maltophilia SeITE02 has been already 
reported.  Actually, the analysis of Sm-SeNPs(-) through Fourier transform 
infrared spectroscopy (FTIR) evidenced the presence of proteins, lipids and 
carbohydrates associated with the nanomaterial (Lampis, 2016) while in Ch-
SeNPs, the same elements are present in different percentage (60.91% in weight 
of C, 4.97% in weight of O, 1.88% in weight of P and 0.63% in weight of S). This 
difference is probably due to the procedure used for the synthesis, where trough 
the bacterial secretion of NPs some organic molecules may bind to the surface of 
nanoparticles. The average sizes has been also investigated using dynamic light 
scattering measurements: Sm-SeNPs(-) showed a size  of 170.6 ± 35.12 nm, Bm-
SeNPs(+) 160.6 ± 52.24 nm and Ch-SeNPs 102.5 ± 29.44 nm (Fig. 6). All three 
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types of SeNPs are able to generate large negative zeta potentials (between -70 
and -80 mV) in solution (Fig. 6) suggesting they are unlikely to form aggregates 
as a neutral and negatively charged NPs. From the literature we know that NPs 
tend to have long half-lives in human serum and are not taken up by cells in a 
nonspecific manner (Alexis, 2008). This is an important information looking at 
nanoparticels as potential in vivo applications as antimicrobial reagents. 
 
 
Table 2. Elemental composition of Ch-SeNPs, Sm-SeNPs(-) and Bm-SeNPs(+) 
calculated through EDAX analysis. 
 
Element Ch-SeNPs Sm-SeNPs(-) Bm-SeNPs(+) 
C 60.91 73.13 75.75 
O 4.97 10.44 10.82 
Se 31.61 11.01 9.26 
P 1.88 4.42 3.14 
S 0.63 1.00 1.04 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. SEM analysis of SeNPs produced by Stenotrophomonas maltophilia 
SeITE02 (I), SeNPs produced by Bacillus mycoides SeITE01 (II) and chemically 
synthesized SeNPs (III). EDAX analysis of biogenic SeNPs (IV). 
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Figure 6. DLS analysis and zeta potential of SeNPs produced by 
Stenotrophomonas maltophilia SeITE02 (I), SeNPs produced by Bacillus 
mycoides SeITE01 (II) and chemically synthesized SeNPs (III). 
 
 
Determination of Minimum Inhibitory Concentration (MIC) for SeNPs against P. 
aeruginosa PAO1 
In a very first part of the study, in order to evaluate the antimicrobial effect of 
biogenic and synthetic SeNPs as well as to understand the putative role of the 
biomolecular cap of the biogenic nanoparticles, we determined the minimum 
inhibitory concentration (MIC) values against the reference strain Pseudomonas 
aeruginosa PAO1 (Tab.3). MIC determination was carried out for the biogenic 
SeNPs (Sm-SeNPs(-) and Bm-SeNPs(+)), the chemically synthesized Ch-SeNPs, 
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the Ch-SeNPs exposed to cell free extract (CFX) of S. maltophilia SeITE02 
(CFX(Sm)-Ch-SeNPs) and B. mycoides SeITE01 (CFX(Bm)-Ch-SeNPs)) and 
CFX of S. maltophilia SeITE02 (CFX(Sm)) and B. mycoides SeITE01 
(CFX(Bm)) alone. With the term CFX is usually indicated the fluid obtained by 
breaking bacterial cells, which contains most of the soluble molecules and 
components present in that microorganisms. We decided to perform this kind of 
experiment to clearly understand if the antimicrobial activity of the biogenic NPs 
was due to the toxicity of the elemental selenium contained in them, to the 
presence of biological molecules derived from the exploitation mechanism or 
both.  
 
 
Table 3. Minimum inhibitory concentration (MIC) values of Sm-SeNPs(-), Bm-
SeNPs(+), Ch-SeNPs, CFX(Sm)-SeNPs, CFX(Bm)-SeNPs, CFX(Sm), CFX(Bm) 
against P. aeruginosa PAO1. 
 
Types of NPs MIC μg/ml 
Sm-SeNPs(-) 8 
Bm-SeNPs(+) 64 
Ch-SeNPs >128 
CFX(Sm)-Ch-SeNPs 256 
CFX(Bm)-Ch-SeNPs 256 
CFX(Sm) >512 
CFX(Bm) >512 
 
 
As we can see from Table 3, Ch-SeNPs, Sm-SeNPs(-) and Bm-SeNPs(+) 
evidenced a different MIC value: the Sm-SeNPs(-) seem to have the highest 
activity against P. aeruginosa PAO1 with a MIC value of 8 µg/ml. On the 
contrary, the NPs synthesized by B. mycoides are less active with an higher MIC 
value (64 µg/ml). Ch-SeNPs showed a very low activity, with an MIC value >128 
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µg/ml towards the strain tested, similar to the one of CFX(Sm)-Ch-SeNPs and 
CFX(Bm)-Ch-SeNPs (256 µg/ml). Finally, CFX alone from both S. maltophilia 
SeITE02 and B. mycoides SeITE01 did not exhibit antimicrobial activity at any of 
the concentration tested. The values obtained are very high  (> 512 µg/ml) thus 
indicating that the isolated cap alone is not responsible for the antimicrobial effect 
of the SeNPs. 
These very preliminary results clearly indicate that the antimicrobial activity 
observed is exactly due to the nanoparticles and the biomolecular cap to them 
associated through the biosynthetic mechanism and not only to the selenium core 
of the NPs or their biomolecular cap.  
Based on these findings, from here on with the term “biogenic selenium 
nanoparticles” we refer to nanoparticles produced by the B. mycoides SeITE01 
and the S. malthophilia SeITE02 strains, composed by a selenium core surrounded 
by a complex capping structure (coating) formed by organic elements as proteins 
and carbohydrates, to date not completely characterized both in its composition 
and structure. 
 
Antimicrobial activity of SeNPs against clinical isolates of P. aeruginosa  
The antibacterial activity of the SeNPs, was tested against a series of clinical 
strains of P. aeruginosa, which, because of their surrounded polysaccharide 
biofilm matrix, are resistant to eradication by antibiotics and to clearance by the 
immune system. Such kind of strains are recurrent in chronic lung diseases as for 
instance Cystic Fibrosis, chronic obstructive pulmonary disease (COPD) and 
asthma. The ability of SeNPs to inhibit bacterial growth was tested by challenging 
the bacterial isolates and reference strains with different concentrations of SeNPs 
according to the Clinical and Laboratory Standards Institute (CLSI, 2016)  broth 
microdiluition method. P. aeruginosa PAO1 and ATCC 27853 were included as 
reference strains. Three strains BR1, BR2 and BR3 were clinically isolated from 
patients through bronchoalveolar lavages. The strains CFC20, CFC21, CFCA and 
CFCB were included being clinical isolates from patient affected by Cystic 
Fibrosis. The TN1 strain was isolated from a nasal swab and the UST1 strain from 
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a burn wound. The P. aeruginosa INT strain, isolated from a urinary tract 
infection, was chosen to provide a particularly challenging target being a 
multidrug-resistant strain that carries a class 1 integron containing multiple 
antibiotic-resistant gene cassettes. 
As shown in Table 4, the MIC of Sm-SeNPs(-) varied widely among the different 
P. aeruginosa strains. Against some clinical isolates from low respiratory tract 
infections (CFC20, CFC21, CFCA,CFCB, BR1 and BR2) and the reference strain 
PAO1 SeNPs showed low MIC values ranging from 8 to 32 µg/ml, while other 
strains as the P. aeruginosa INT and BR3 presented MIC values ranging from 64 
to 256 µg/ml. Finally, among the strains considered, two clinical isolates (TN1 
and FUS1) as well as the reference strain ATCC27853 seemed to have high MIC 
values ranging from 256 to 512 µg/ml.  
The MIC of Bm-SeNPs(+) also varied among the strains but was generally 2–4 
times higher than Sm-SeNPs (Table 4). The MIC of Ch-SeNPs indicated that 
these SeNPs are no effective against the bacterial growth of P. aeruginosa 
(Tab.4).  
We investigated also the antibiotic susceptibility of the same strains by calculating  
the MIC values, according to the CLSI standard method. The analysis 
demonstrated that the P. aeruginosa clinical strains were resistant to beta-lactams 
(MIC values varying between 16 and ≥ 64 µg/ml) and other antibiotics such as 
gentamicin (MIC values 8-16 µg/ml), ciprofloxacin (MICs between 2 and ≥ 4 
µg/ml) and sulphonamides (MIC values 20-320 µg/ml).  
However, a possible correlation between the SeNPs susceptibility (Tab.4) and the 
antibiotic resistance reported above is not conceivable.  
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Table 4. Minimum inhibitory concentration (MIC) values of Sm-SeNPs(-), Bm-
SeNPs(+) and Ch-SeNPs against different P. aeruginosa reference and clinical 
strains. 
 
Strain Name  MIC µg/ml  
Sm-SeNPs (-)  Bm-SeNPs(+) Ch-SeNPs  
PAO1  8  64 >128  
ATCC27853 512 512 >512 
INT  64  512 >512  
BR1  32  128 >512  
BR2  8  128 >512 
BR3 256 512 >1024 
CFC20 16 64 128 
CFC21 8 32 128 
CFCA 16 64 >128 
CFCB 16 32 >128 
FUS1 512 >1024 >1024 
TN1 512 >1024 >1024 
 
 
To tentatively evaluate the susceptibility of bacterial strains to SeNPs, the MIC 
values obtained were compared to those obtained using antibiotics. Lacking 
reference MIC values (breakpoints) which could help us in determining the 
sensitivity or the resistance to the SeNPs, we can only refer to the obtained values 
in term of low or high and try to compare these results to the ranges of antibiotics 
clinical exposure. 
Because the MIC values of SeNPs for some of the clinical isolates and the 
reference strain PAO1 fall within the range of clinical exposures adopted during 
typical antibiotic treatments (Tab.4), we can hypothesize that biogenic SeNPs 
could be used to treat antibiotic resistant clinical strains, eventually overcoming 
the potential risks of antibiotic resistance manifestation. Moreover, in some cases 
the MIC values of biogenic SeNPs is lower than those of antibacterial drugs 
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supporting the idea of these new nanomaterial as a possible alternative strategies 
in the fighting of drug-resistant bugs. 
 
Inhibition of P. aeruginosa strains biofilm formation by SeNPs  
The effect of SeNPs on P. aeruginosa biofilm synthesis was analyzed treating the 
clinical isolates  showing low or intermediate MIC values to SeNPs and the two 
reference strains PAO1 and ATCC27853 with different concentrations of Sm-
SeNPs(-), Bm-SeNPs(+) and Ch-SeNPs for 24 h at 37°C. Biofilm formation was 
quantified by methylene blue staining as previously described. The percentage of 
biofilm inhibition was calculated by comparing the microbial cultures exposed to 
the SeNPs with a  culture control growing in the absence of SeNPs. As seen in 
Tables 5 and 6, the quantity of  biofilm produced by P. aeruginosa varied among 
the different strains as reported in brackets but all the strains were considered 
efficient biofilm producers. The lowest concentrations of biogenic SeNPs used 
(50 and 100 µg/ml) inhibited biofilm synthesis by P. aeruginosa strains CFC20, 
CFC21 and CFCA by 70-90%, and confirmed that NPs are particularly active 
against these strains as previously indicated by MIC values (Tab.5). In contrast, in 
the clinical strains CFCB and INT, as well as in the reference strains, SeNP 
showed a significant inhibition of biofilm synthesis (at least 70%) only in the 
presence of concentrations ≥ 250 µg/ml. Surprisingly, the BR3 strain, showed a 
very resistant biofilm against the action of SeNPs with an inhibition of 50% only 
up to 500 µg/ml. Table 5 also shows that Sm-SeNPs(-) were usually more 
efficient than Bm-SeNPs(+) and that the synthetic Ch-SeNPs were only active at 
concentrations of 250–500 µg/ml against most of the strains, the exception being 
P. aeruginosa CFC20, which was the most susceptible isolate tested.  
 
Degradation of P. aeruginosa biofilms by SeNPs 
We next investigated whether the SeNPs were able to cause the degradation of 
biofilms by measuring the amount of biofilm remaining after exposing for 24 h 
the mature synthesized exopolysaccharide matrix to different concentrations of 
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biogenic and synthetic SeNPs (Tab.6). Also in this case, the P. aeruginosa CFC20 
biofilm was highly susceptible to SeNP-induced disaggregation, resulting in 90% 
degradation in the presence of 50 µg/ml SeNPs, confirming that this strain is more 
susceptible to SeNPs than the other strains. In all the strains, the biofilm 
degradation did not increase at higher SeNPs concentrations. Sm-SeNPs(-) were 
slightly more efficient than Bm-SeNPs(+) in the eradication of P. aeruginosa 
biofilms. As regard the reference strains, the biofilm formed by PAO1 can be 
considered highly susceptible to SeNPs activity, showing a disaggregation of 
more than 70% also at the lowest concentration. Conversely, against the reference 
strain ATCC27853 and the clinical isolates INT, CFCB and CFCA as well, SeNPs 
demonstrated a lower disaggregating activity ranging from 40 to 60% for all the 
concentration tested. Only one of the clinical isolates, the P. aeruginosa CFC21, 
was not sensitive to the SeNPs disaggregating activity, showing only a 20% 
reduction of the exopolysaccaride matrix. Similarly to the inhibiting activity, the 
Ch-SeNPs had not a good antibiofilm activity. The difference between the MIC 
values and the inhibiting and disaggregating activity among the same strain was 
probably due to the type, the quantity and the thickeness of biofilm formed by the 
different strains.  
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Table 5. Percentages of inhibiting activity in different Pseudomonas aeruginosa strains caused by Sm-SeNPs, Bm-SeNPs and Ch-
SeNPs (mean±SD). 
 
Table 6. Percentages of disaggregating activity in different Pseudomonas aeruginosa strains caused by Sm-SeNPs, Bm-SeNPs and 
Ch-SeNPs (mean±SD). 
Strain name Se NPs-Sm (-) µg/ml Se NPs-Bm (+) µg/ml Ch Se NPs µg/ml 
50 100 250 500 50 100 250 500 50 100 250 500 
PAO1 40±2.5 45±3 70±2.5 96±1 33±3 47±6 63±4.5 95±1.2 9±0.7 21±2.1 94±0.7 96±1.4 
ATCC27853 15±0.7 30±0.7 41±0.7 66±2.1 15±4.2 17±2 44±2.8 64±1 4±1.4 10±0.7 35±2.1 44±2 
INT 23±1 34±1 59±3.5 95±1 25±4.5 29±3.5 49±2.5 94±1.5 2±3.5 2±1.4 20±0.7 30±0.7 
BR1 71 ± 0.7 75 ± 2.1 73 ± 6 76 ± 4.9 20 ± 1.4 30 ± 4.2 28 ± 0.1 50 ± 3.5 7 ± 0.1 10 ± 4.9 13 ± 5.6 16 ± 1.4 
BR2 75 ± 4.9 69 ± 7 74 ± 4.2 69 ± 3.7 22 ± 1.4 33 ± 1.2 45 ± 0.7 60 ± 3.5 0 0 26 ± 2.8 59 ± 2.8 
CFC21 66±5 86±0.5 95±2 96±1.5 37±5.5 66±3.5 93±1.7 95±2 10±3.5 33±3.5 71±1.4 65±1.4 
CFC20 75±0.5 82±1 86±1 93±1.5 72±2 76±0.5 85±1 91±2 53±0.7 90±0.7 95±1 95±1 
CFCA 39±1 94±1 94±3.5 96±1 25±5 25±1.5 94±0.5 96±1 5±0.7 6±0.7 96±1 97±1.5 
CFCB 31±1 39±3 39±2 88±4 28±1.5 34±5 81±4.5 85±5 1±0.5 1±0.5 97±0.7 98±1 
Strain name Se NPs-Sm (-) µg/ml Se NPs-Bm (+) µg/ml Ch Se NPs µg/ml 
50 100 250 500 50 100 250 500 50 100 250 500 
PAO1 73±5 72 ±2 76 ±2 73±5 52±1 62±4.5 57±1 73±6 16±0.7 18±4.2 37±0.7 53±1 
ATCC27853 49±1.4 53±1.4 53±1.4 43±0.7 31±4.9 43±1.4 51±7 45±7 23±1.4 35±1 40±2.5 46±0.7 
INT 63±5.5 53±0.5 61±1.5 41±4.5 65±4.5 44±0.5 58.2±3 32±1.5 15±6.3 15±6.3 8±2.8 8±4.5 
BR1 23±3.5 28±3.7 44±3 40±0.7 2±4.9 2±4.9 14±2.8 10±1.4 10±1.2 14±2 21±0.7 19±1 
BR2 14±4.9 10±0.1 36±4.1 43±6.3 10±1.4 7±3.5 17±0.1 19±4.1 0 6±1.2 9±0.7 8±0.1 
CFC21 21±1 45±3.5 53±5.5 63±2 44±4.5 16±3 33±1.5 61±0.5 8±1.4 5±0.7 16±1.4 1±0.7 
CFC20 87±3 84±0.5 85±1 85±0.5 80±1 86±1 86±1.7 82±2 17±3.5 13±2.8 29±4.2 50±2.8 
CFCA 53±4 58±3 56±3 64±2 25±1 27±5 51±2.5 47±3 0 4±1.4 57±1.4 72±0.7 
CFCB 44±2.5 44±2.5 39±1 53±2 28±4 20±2.5 40±2.5 53±1 0 2±0.7 66±0.7 73±0.7 
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Antimicrobial activity of SeNPs against clinical isolates of Candida  
Table 7. Minimum inhibitory concentration (MIC) values of Sm-SeNPs(-), Bm-
SeNPs(+) and Ch-SeNPs against different yeasts strains. 
 
Yeast strain MIC µg/ml 
Sm-SeNPs(-) Bm-SeNPs(+) Ch-SeNPs 
C. albicans CVr-21 64 256 >512 
C. parapsilosis CPVr-5 64 128 >512 
 
We also evaluated the anti-fungal activity of SeNPs by testing in vitro their ability 
to inhibit the growth of C. albicans and C. parapsilosis clinical strains. The 
SeNPs from Stenotrophomonas malthophilia SeIT02 resulted to have mild MIC 
values (64 µg/ml) against the three strains tested. The NPs from Bacillus mycoides 
SeIT01 and chemically synthesized resulted poorly effective against Candida 
strains with MICs values raging from 128 to more than 512 µg/ml. 
 
Inhibition of the formation and degradation of Candida strains biofilm by SeNPs  
Then the inhibiting and disaggregating activity of SeNPs was evaluated on 
Candida biofilms (Tab.8). Interestingly, the lowest SeNP dose tested (50 µg/ml) 
was sufficient to inhibit biofilm formation for 60–70% in the two yeast isolates, 
and no significant improvement was achieved at the higher doses of 100 and 250 
µg/ml tested (Tab.9). Sm-SeNPs(-) and Bm-SeNPs(+) had similar effects on 
biofilm formation in the yeast strains, whereas the Ch-SeNPs had no significant 
effect. 
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Table  8. Percentage of biofilm synthesis inhibition in different fungal strains caused by Sm-SeNPs(-), Bm-SeNPs(+), Ch-SeNPs 
(mean±SD). 
Strain name Sm-SeNPs(-) Bm-SeNPs(+) Ch-SeNPs 
 50 100 250 500 50 100 250 500 50 100 250 500 
CVr-21 61±0.5 60±3 60±1 94±1 60±6.5 69±2 74±2.5 93±0.5 0 0 0 9±0.7 
CPVr-5 72±1.5 79±0.5 73±1 95±1 75±1.5 73±0.5 72±3 94±0.5 0 0 0 5±0.7 
 
 
 
Table 9. Percentage of biofilm disaggregation in different fungal strains caused by Sm-SeNPs(-), Bm-SeNPs(+), Ch-SeNPs 
(mean±SD). 
Strain name Sm-SeNPs(-) Bm-SeNPs(+) Ch-SeNPs 
 50 100 250 500 50 100 250 500 50 100 250 500 
CVr-21 26±2.5 43±2.5 47±3.5 60±2 11±2.5 32±2 48±1.5 60±3.5 0 0 2 0 
CPVr-5 52±2 48±1.5 48±2.5 64±2 48±3 38±2 47±2 42±2.5 0 1 0 0 
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5.2 INVESTIGATION OF THE BIOGENIC COATING AS A POSSIBLE 
MODULATOR FOR THE SeNPs ANTIMICROBIAL AND ANTIBIOFILM 
ACTIVITY 
In a fist part of the study we demonstrated that biogenic selenium nanoparticles 
produced by two different environmental isolates were able to inhibit biofilm 
synthesis by P. aeruginosa and can efficiently disaggregate the mature 
exopolysaccharide matrix produced by these microorganisms. The antimicrobial 
potential of these biogenic SeNPs is greater than that of synthetic SeNPs, 
probably due to the presence of a bacterial protein layer coating the surface of the 
NPs. Furthermore, SeNPs produced by the Gram-negative species S. maltophilia 
are more efficient antibacterial and antibiofilm agents than those produced by the 
Gram-positive species B. mycoides. This could suggest that SeNPs with similar 
dimensions but originating from taxonomically distinct bacterial isolates may 
show different activities, probably due to the different composition of their 
organic surface layer. 
In a second part of the study, in order to evaluate the influence of this organic 
matter on the physical characteristics of biogenic nanoparticles, different and 
progressively more aggressive denaturant treatments were applied to the Sm-
SeNPs(-). Taken in consideration that the NPs produced by the Gram-negative 
strain S. maltophilia were more active against the strains tested, we decided to 
focus our attention on this type of biogenically produced nanoparticles. 
The macromolecular contents and the physical and electrical properties were 
determined in each type of SeNPs including those obtained after treatments. The 
SeNPs obtained after the three different denaturing treatment were then tested for 
their antibacterial and antibiofilm activity and compared to the SeNPs 
biogenically produced by S. malthophilia SeITE02 (Untreated) in order to 
correlate the composition and the presence of the whole coating on the surface of 
the NPs and their antimicrobial activity.  
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Characterization of Sm-SeNPs(-) as biogenic products and after different 
denaturing treatments 
As shown in Figure 7, the protein content associated with the organic coating of 
SeNPs decreases after the different denaturant treatments. Biogenic SeNPs present 
protein concentration of 0.46±0.05 mg/mgNPs that progressively decreases with 
the increase in treatment intensity reaching a value of 0.05±0.01 mg/mgNPs after 
exposure to 10% sodium dodecyl sulfate (SDS) and 30 min boiling. A similar 
pattern was observed for carbohydrate concentration (Fig.5B): untreated biogenic 
SeNPs present a concentration of 0.33±0.04 mg/mgNPs which decreases after the 
different treatments reaching a value of 0.02±0.01 mg/mgNPs. 
Dynamic light scattering measurements (Tab.10) showed that the exposure to 
different treatments induced a progressive increasing of the nanoparticles size, up 
to 270±24nm,  after the treatment with 10% SDS and 30 min boiling. More 
precisely, as shown in Figure 8, the loss of cap is associated to an increase in the 
number of SeNPs with high trend to aggregation and not to the formation of 
SeNPs with higher dimensions. On the other hand, nanoparticles showed a 
reduction of Z-potential with values ranging between -17.40 and -3.97 mV after 
the different treatments (Tab.10). Figure 8 describes in detail the changes 
associated with the denaturing conditions indicating that there is an increase both 
in size and in the agglomeration state in a high number of the NPs due to the 
removal of the organic coat. 
With the aim to demonstrate that the decreasing antibacterial activity of the 
completely denaturated SeNPs (treatment with 10%SDS+30’ boiling) was not 
only due to the biggest dimension but also to the complete loss of the coating 
surrounding the surface of the NPs, another type of SeNPs (Sm-SeNPs(48)) was 
also taken into consideration. These Sm-SeNPs(48) were obtained from bacterial 
cultures after 48 hours of incubation with sodium selenite and showed a diameter 
of  276±26 nm, with a Z-potential value of -29.27 mV (Tab.10). In fact, Lampis et 
al (Lampis, 2014) demonstrated that the size of SeNPs is dependent on the 
incubation times: by increasing the incubation time is possible to produce 
biogenic particles with a grater size.  
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Figure 7. Protein (A) and carbohydrate (B) content on the coating of Sm-SeNPs(-) 
after different denaturant treatments compared to the native SeNPs (first column) 
(mean±SD; n=3; p<0.05).  
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Table 10. DLS analysis and zeta potential of Sm-SeNPs(-) as biogenic product, 
after different treatments and after 48 h of incubation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Diameter distribution of SeNPs extracted from Stenotrophomonas 
maltophilia SeITE02. Biogenic SeNPs (A), SeNPs after treatment with 10% SDS 
 
 
Diameter (nm) Ζ-potential (mV) 
SeNPs 
 
181±20 -32.01±2.67 
10%SDS 
 
209±25 -17.40±3.45 
10%SDS+10min boiling 
 
233±19 -10.02±2.36 
10%SDS+30min boiling 
 
270±24 -4.06±1.34 
Sm-SeNPs(48) 276±26 -29.27±2.5 
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(B), SeNPs after treatment with 10% SDS +10 min boiling (C), SeNPs after 
treatment with 10% SDS + 30 min boiling (D). 
 
Characterization and antimicrobial activity for Sm-SeNPs(48) 
SeNPs extracted after 48h of incubation with Stenotrophomonas maltophilia 
SeITE02 were first of all characterized for chemical and physio-chemical 
characteristics. Sm-SeNPs(48) showed a diameter of 276±26 nm, with a Z-
potential value of -61.16 mV (Tab.10), which is an indicator of the surface charge 
on SeNPs and consequently of their stability. As shown in Fig.9 the proteins 
concentration associated with these biogenic nanomaterials was 0.48±0.07 
mg/mgSeNPs, while the carbohydrates concentration was 0.35±0.03 
mg/mgSeNPs. Comparing the size distribution of the different types of NPs to the 
one of the Sm-SeNPs(48) (Fig.8 and Fig.9) we can clearly notice that they had 
similar dimensions while the percentage of biomolecules supposed to form the 
organic coating is completely different, especially comparing the Sm-SeNPs(48) 
with the ones treated with the harsher conditions (10%SDS+30’boiling). The MIC 
values of the Sm-SeNPs(48) were measured against four selected strains, two P. 
aeruginosa (PAO1 and BR2), S. maltophilia VR20 and S. aureus UR1 (Tab.11) 
and compared to the other types of nanoparticles. Depending on the strain tested, 
the results obtained evidenced variable MIC values between 16 to 256 µg/ml, 
generally 1-2 times higher than the values obtained with the untreated Sm-SeNPs.  
 
 
 
 
 
 
 
Figure 9. Distibution (A), protein and carbohydrate concentrations (B) of biogenic  
A B 
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SeNPs produced by S. maltophilia after 48 h of incubation (average±SD; n=3). 
 
Antimicrobial activity of the various kinds of  selenium nanoparticles  
Some of the P. aeruginosa strains used for the first part of the study and a number 
of other bacterial strains belonging to different species were screened for their 
susceptibility to native and treated SeNPs. This to underline and evaluate the 
susceptibility to SeNPs among different bacterial species and different bacterial 
strains among the same species. The selection was made on the basis of the 
frequent involvement of these strains in infections mediated by biofilm: this is the 
case of the well-known P. aeruginosa and Burkholderia cenocepacia and the 
emergent Achromobacter xylosoxidans and Stenotrophomonas maltophilia 
pathogens causing chronic lung infections in cystic fibrosis and other respiratory 
diseases (Bjarnsholt, 2013). Four strains of P.aeruginosa were tested: the clinical 
isolates from a bronchial lavage BR1 and BR2, the MDR strain P. aeruginosa 
INT and the reference strain PAO1. Two strains of S. maltophilia (VR10 and 
VR20), both isolated from patient affected by low respiratory infections and the B.  
cenocepacia LMG16656 isolated form a patient affected by cystic fibrosis were 
also included. Finally the A. xylosoxidans C strain, from a low respiratory 
infection, and the Acinetobacter baumanii LMG 10531, isolated from a wound 
infection, were used as representatives of that class of Gram-negative 
microorganisms which have become challenging to treat due to the increasing 
appearance of multi drug resistance among these bacterial species (Chan-
Tompkins, 2011)  
In this second part of the study also Gram-positive species were taken into 
account. Two S. aureus strains were considered: the MDR Mu50, as reference 
strain, and the clinical isolate from an urine sample UR1. The S. epidermidis 
ET024, clinically isolated from an endotracheal tube, and the S. haemolyticus 
UST1, isolated from a burn wound, were also tested. It is well known that 
staphylococci are important producers of biofilms associated with infections from 
medical devices and skin pathologies (Paharik, 2016). Moreover, also the 
Propionibacterium acnes LMG16711 isolated from a human facial acne sample, 
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was included in the study as another representative of another Gram-negative 
species. 
As shown in Table 11, in accordance to the results obtained in the first part of the 
study, the MIC values of biogenic SeNPs varied widely among the different 
microbial species and even among various strains belonging to the same species, 
ranging from 4 to 64 µg/ml.  
Looking at the results is evident that some of the Gram-negative strains tested 
showed low MIC values ranging from 4 to 16 µg/ml. Is the case of the P. 
aeruginosa PAO1 and BR2 strains, the B. cenocepacia LMG16656 and the A. 
Baumanii LMG10531. Five of the nine Gram-negative strains tested showed mild 
MIC values of 32-64 µg/ml. As regard the Gram-positive strains, the UR1, UST1 
and ET024 staphylococci and the P.acnes LMG16711 strain showed a very low 
MIC values form 4 to 16 µg/ml. Only one of the strains tested, the S. aureus 
Mu50, demonstrated the highest MIC value of 128 µg/ml, probably due to the 
presence of the capsule.  
Then, we decided to evaluate the possible effect of removing the SeNP cap, on 
their antibacterial activity. For this purpose, we tested the antimicrobial effect of 
the SeNPs as biogenic products and after different denaturing treatments. Data 
reported in Table 11 showed, for almost all the strains evaluated, a decrease in the 
SeNP activity with the progressive denaturation of the coat surrounding the 
nanoparticles, as indicated by progressively higher MIC values.  
The antimicrobial activity of Sm-SeNPs(48) was also evaluated to test the 
bioactivity of SeNPs showing a size similar to that of the completely denatured 
nanoparticles (treatment 3) but surrounded by the organic cap. What we observe is 
that the increase in NP size and the induction of the aggregation state, associated 
to the loss of antibacterial effect, seems to be mediated by the loss of the organic 
coat surrounding the NPs. In fact, the removal of this coat causes an increase in 
aggregation and size of NPs, a change in their electric properties (Tab.10) and a 
loss of the antibacterial activity (Tab.11). 
To prove that, we used those strains that have shown the gradually lowest SeNPs 
activity after various denaturing treatments, namely P. aeruginosa PAO1, P. 
aeruginosa BR2, S. maltophilia VR20 and S. aureus UR1. As reported in Tab.10, 
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the MIC values were lower than those obtained with completely denatured SeNPs. 
The experiments conducted with the different denaturant treatments together with 
the one performed with Sm-SeNP(48) highlighted that the organic coating is in 
some way involved in the antibacterial activity of NP. The completely denaturated 
NPs are less efficient against the microorganisms tested not only for their bigger 
dimensions but also for the lack of organic surface elements. 
 
 
Table 11. MIC of different types of SeNPs against various bacterial strains. 
Untreated: native biogenic SeNPs; Treatment 1: 10% SDS; Treatment 2: 10% 
SDS+10 min boiling; Treatment 3: 10% SDS+30 min boiling, Sm-SeNPs(48): 
SeNPs obtained after 48 h of incubation. 
 
Bacterial 
species 
Strain 
name 
MIC µg/ml 
Untreated 
SeNPs 
Treatment 
1 
Treatment 
2 
Treatment3 Sm-
SeNPs(48) 
P. aeruginosa PAO1 8 16 128 64 16 
P. aeruginosa INT 64 512 >512 >512 - 
P. aeruginosa BR1 32 64 32 64 - 
P. aeruginosa BR2 8 16 32 128 32 
S. maltophilia VR10 32 16 32 64 - 
S. maltophilia VR20 64 256 512 >512 256 
A. xylosoxidans C 64 >512 >512 >512 - 
B. cenocepacia LMG16656 16 16 32 32 - 
A. baumanii LMG10531 8 16 32 128 - 
S. aureus Mu50 128 128 256 512 - 
S. aureus UR1 4 16 32 64 16 
S. haemolyticus UST1 16 8 32 64 - 
S. epidermidis ET024 4 8 16 64 - 
P. acnes LMG16711 8 8 16 32 - 
C. albicans  SC5314 64 128 >512 >512 - 
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Anti-biofilm effect of untreated and treated SeNPs  
Subsequently, the anti-biofilm effect of the different types of SeNPs, either as 
native products or after various denaturant treatments, was evaluated. These 
experiments were conducted on a selection of strains, namely three strains of P. 
aeruginosa (PAO1, BR1 and BR2), the B. cenocepacia LMG16656 strain and the 
S. haemolitycus UST1 strain. These were chosen on the basis of their low MIC 
values and the fact they are efficient biofilm formers. On the other hand, the 
methicillin-resistant and vancomycin-intermediate (VISA) strain S. aureus Mu50 
was also examined, being resistant to antibiotics and SeNPs. Based on the results 
obtained in the first part of this whole study, the anti-biofilm activity of the 
different NP types was tested using a selenium nanoparticles concentration 
representing the lowest concentration having a significant effect on biofilm 
formation (128 µg/ml). 
First the total biofilm biomass was quantified the using crystal violet (CV) 
staining. The CV stain measured the total biofilm biomass grown, in the case of 
the strains tested, on the bottom and on the walls of the microwells. Then, the 
number of culturable cells (colony forming units/ml, CFU/ml) still present within 
the biofilms was determined after their removal and plating on a growth medium. 
For all  P. aeruginosa strains, exposure of  biofilms to 128 µg/ml of
  
various types 
of SeNPs resulted in a clear decrease in the CV signal: this was more pronounced 
with untreated SeNPs than with completely denaturated SeNPs (Fig.10A). The 
number of culturable cells per ml of P. aeruginosa PAO1 decreased significantly 
after treatment with all kind of SeNPs tested except when completely denaturated 
NPs were used (Fig.10B); the number of CFU/ml recovered from P. aeruginosa 
BR1 and BR2 biofilms decreased significantly only when exposed to the 
untreated SeNPs (Fig.10B) that showed the highest bactericidal activity with a 
reduction of 5-2 log10 CFU/ml, depending on the strain considered. A particularly 
interesting case is that of B. cenocepacia LMG16656, which produces a very 
susceptible biofilm that is completely disaggregated by all the SeNP types, 
including completely denatured nanoparticles. Also the number of culturable cells 
recovered from these biofilms was, in any experimental condition, significantly 
lower than the control biofilms (Fig.11). Regarding the untreated SeNPs we 
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obtained a 7 log10 reduction in the number of cells still present in the biofilm after 
challenging, while for the other types of NPs the number of CFU/ml is reduced by 
about 3 logarithms. 
Despite its low susceptibility to the action of SeNPs in the planktonic state (MIC 
of 128 µg/ml), the Mu50 strain of S. aureus produced a biofilm matrix easily 
degradable by any type of SeNPs. The results showed a decrease in the number of 
culturable biofilm bacterial cells after treatment with the untretaed nanoparticles 
with a significant difference of 5 log10 if compared to the control. The reduction in 
the number of CFU/ml is progressively less evident when treated SeNPs were 
applied. Surprisingly, the S. haemolyticus UST1 represented a different case, as 
we can see from the figure is possible that this strain synthesizes a very SeNP-
resistant biofilm and showed no decrease in the culturable cell number after any 
nanoparticle treatment (Fig.11).  
Comparing the effects on biofilm biomass and cell viability between the different 
types of SeNPs tested (Fig.10 and 11) it is evidenced a significant difference not 
only referred to the control but also among the various denaturing treatment 
applied to the NPs. In all the strains tested, except for the S. haemolyticus UST1 
strain, the progressive loss of the biomolecular cap on the surface on NPs is 
related to a progressive loss of their antimibiofilm activity demonstrated by an 
increasing value of CV signal and increasing number of CFU/ml. The statistic 
analysis reported, indeed point out a significant difference especially between the 
antibiofilm activity of the untreated NPs and the ones exposed to the harsher 
denaturing treatment (Treatment 3) able to remove and denaturate the majority of 
the capping molecules present on the surface of the nanoparticles. 
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Figure 10. Anti-biofilm activity of  different types of SeNPs measured by CV 
staining (effect on bioﬁlm biomass) (A) and colony counting (effect on cell 
viability) (B), compared to a bioﬁlm grown in the absence of SeNPs (Control) as 
regard P.aeruginosa strains PAO1, BR1 and BR2 (n=3, Average ±SEM; p<0.05).  
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Figure 11. Anti-biofilm activity of different types of SeNPs measured by CV 
staining (effect on bioﬁlm biomass) (A) and colony counting (effect on cell 
viability) (B), compared to a bioﬁlm grown in the absence of SeNPs (Control) as 
regard B. cenocepacia LMG 16656, S.aureus Mu50 and S. haemoliticus UST1 
(n=3, Average ±SEM; p<0.05). 
80 
 
Fluorescence microscopy 
In Figure 13 are reported the images of different biofilms observed at fluorescence 
microscope after staining with Live/Dead dye. Comparing the control biofilms to 
the treated with 128 µg/ml of Sm-SeNPs(-) we can clearly notice that the structure 
of the biofilm matrix is completely different in the treated ones. The major 
difference seems to be in the number and not in the viability of cells still 
remaining in biofilms: as reported by CV assay there was a clear decrease in the 
staining signal but not in cell viability. Even if there was a lower number of cells 
they are still able to replicate on the growth medium (CFU/ml).  
 
Ros production 
The production of reactive oxygen species (ROS) in response to SeNPs treatment 
was analysed in the three selected strains P. aeruginosa PAO1, S. aureus Mu50 
and B. cenocepacia LMG16656. As shown in Figure 12, for all bacterial strains 
tested there was an increase in the quantity of ROS produced after treatment with 
biogenic nanoparticles compared to the untreated controls. Reactive oxygen 
species are important elements in the bacterial response to lethal stress and have 
been associated with the killing action of multiple antimicrobial agents (Van 
Acker, 2017). 
 
 
 
 
 
Figure 12. Formation of ROS in P. aeruginosa PAO1, B. cenocepacia 
LMG16656, S. aureus Mu50 planctonic cells exposed to 128 µg/ml of SeNPs for 
24 hours normalized to cells not exposed to NPs (Control) (n=3; Average ± SEM; 
p<0.05). 
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Figure 13. Fluorescence microscopy images of different bacterial biofilms treated 
with 128 µg/ml Sm-SeNPs(-) (B) compared to a non treated control (A). 
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5.3 EVALUATION OF THE POSSIBLE SYNERGIC EFFECT OF 
BIOGENIC SELENIUM NANOPARTICLES AND ANTIBIOTICS 
Then we investigated  the possible in vitro synergistic antibacterial and 
antibiofilm activities of biogenic Sm-SeNPs(-) in combination with some 
conventional antibiotics. For this part of the study we focused our attention on 
those strains that showed the greater antibiotic resistance and we compared them 
to reference strains belonging to the same bacterial species. Specifically, we 
analyzed the P. aeruginosa INT strains, isolated from an human urine sample. 
This strain was considered particularly relevant showing the presence of a class 1 
integron, that confer resistance to a large panel of antibiotics. A second interesting 
strain used was the S. aureus Mu50 strain, originally  isolated from a burn wound 
and considered a reference strain, was selected being a Vancomycin Intermediate- 
and Methicillin-resistant. P. aeurginosa PAO1 and S. aureus UR1 (isolated from 
an urine sample and showing a great antibiotic susceptibility) were also included 
in the study.  
The strains selected were first tested for their antibiotic susceptibility against 
various antimicrobial drugs, commonly used in the clinical practice. Among those 
compound we highlighted the one to whom the strains tested showed a resistance. 
For Pseudomonas strains Clarithromycin, a protein synthesis inhibitor, 
Tobramycin, a protein synthesis inhibitor frenquently used in patient affected by 
Cystic Fibrosis, and Trimethoprim/Sulfametoxazole, an inhibitor of folate 
synthesis, were used. For S. aureus strains we selected Levofloxacin, an inhibitor 
of DNA replication, Oxacillin and Vancomycin,  two inhibitor of the synthesis of 
bacterial cell walls. Usually, the resistance to Oxacillin correlates with the 
resistance to the whole class of β-lactams.  
The FIC index of Sm-SeNPs(-) and the various antibiotic combination were 
summarized in Tables 12 and 13. Nanoparticles were able to potentiate the effect 
of Clarithromycin against P. aeruginosa PAO1 strain (FIC ≤ 0.5) and partially 
potentiate the effect of Trimethoprim/Sulfametoxazole and Tobramycin (FIC ≤ 1) 
(Tab.12). The antibiotic effect of the three different agents tested against P. 
aeruginosa INT strain is partially potentiated by the combination with NPs (0.5 ≥ 
FIC ≤ 1). As regard the S. aureus strains, for both Levofloxacine and Vancomycin 
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there is a synergistic activity (FIC ≤ 0.5) with SeNPs (Tab.13). On the contrary, 
the combination of SmSeNPs and Oxacillin, results in a partial synergic or 
additive effect for S. aureus UR1 and Mu50 respectively. 
 
Table 12. Fractional inhibitory Concentration (FIC) index of P. aeruginosa PAO1 
and INT strains for the combination of Sm-SeNPs(-) and Clarithromycin, 
Tobramycin and Trimethoprim/Sulfametoxazole (n=3).  
 
 
Table 13. Fractional inhibitory Concentration (FIC) index of S. aureus Mu50 and 
UR1 strains for the combination of Sm-SeNPs(-) and Levofloxacyn, Oxacillin and 
Vancomycin (n=3). 
 
 
Antibiofilm activity of different combination of SeNPs and antibiotics 
The antibiofilm activity of different combinations of antibiotics and nanoparticles 
was tested using a concentration of 128 µg/ml of SeNPs, considered the lowest 
concentration having a significant effect on biofilm formation, as previously 
Bacterial 
strain 
Clarithromycin Tobramycin 
Trimethoprim/ 
Sulfametoxazole 
 
FIC 
index 
Outcome 
FIC 
index 
Outcome 
FIC 
index 
Outcome 
P. aeruginosa 
PAO1 
0.5 Synergy 1 Additive 1 Additive 
P. aeruginosa 
INT 
0.56 
Partial 
synergy 
0.75 
Partial 
Synergy 
1 Additive 
Bacterial 
strain 
Levofloxacin Oxacillin Vancomycin 
FIC 
index 
Outcome FIC 
index 
Outcome FIC 
index 
Outcome 
S. aureus 
Mu50 
0.5 Synergy 0.6 Partial 
Synergy 
0.5 Synergy 
S.aureus UR1 0.5 Synergy 2 Additive 0.5 Synergy 
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demonstrated, combined to a concentration 2×MIC of CLA (Clarithromycin) and 
TRIM (Trimethoprim/Sulfametoxazole) for P. aeruginosa strains. Antimicrobial 
activity of 128 µg/ml SeNPs against S.aureus strains was tested in addition to 
2×MIC of both LEV (Levofloxacine) and VAN (Vancomycin). The concentration 
of antibiotics used was decided basing on the idea that the tolerance of mature 
biofilms against most antimicrobial agents is often many times higher, if 
compared with their planktonic counterpart (Bjarnsholt, 2013). We decided to 
combine the SeNPs and antibiotics at the same time because in previous 
experiments (data not shown) we tested the activity of a 2 h NPs treatment 
followed by a 22 h treatment of antibiotic with no significant reduction neither in 
biofilm biomass nor in cell viability.  
First, the biofilm biomass was quantified using Crystal Violet staining (CV 
assay). Then the number of culturable cells (CFU/ml) still present in the mature 
biofilms after treatment, was quantified by plaiting on TSA growth medium. The 
results obtained for P. aeruginosa biofilms (Fig.14) showed that this reference 
strain was more susceptible to SeNPs than to CLA and TRIM, resulting in a clear 
disaggregation of mature biofilm with a low value of CV signal and a significant 
decrease in the number of CFU/ml. Is interesting to notice that the antibiofilm 
activity of antibiotics combined with NPs is very similar to the one of the SeNPs 
alone and more pronounced than the one of the antibacterial agents alone. 
Particularly interesting is the case of the multi-drug resistant P. aeruginosa  INT 
strain: despite the low susceptibility to antibiotics due to the carrying of a class 1 
integron, the combination with SeNPs potentiate the antibacterial activity with a 
clear reduction in the biofilm biomass (CV signal) and in the number of CFU/ml 
(Fig.14) with a significant difference of 2-3 log10 compared to the non treated 
control and compared to the SeNPs or CLA/TRIM alone. The combination with 
SeNPs do not exhibit a synergistic antibiofilm effect, the activity of the 
combination of NPs and antimicrobial drugs is very similar to the one of 
nanoparticles alone. Thus suggesting that the SeNPs can be considered a more 
potent antibiofilm agent than the common antimicrobial drugs. Very relevant are 
the results regarding the MRSA and VISA strain Mu50 (Fig. 15) were we can 
observe that the SeNPs had greater effect on the biofilm than the antibiotic alone. 
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Also the combination between the two, seemed to be more effective than the 
antibiotic treatments. Figure 15 shows the effect of Levofloxacine or Vancomycin 
and SeNPs as well as their combination, on 24 h old S. aureus biofilms. The NPs 
alone had substantial effect on S. aureus Mu50 and UR1 biofilms but no effect is 
reported when treated with LEV or VAN alone.  
 
Figure 14. Antibiofilm activity of  SeNPs (128 µg/ml) alone and in combination 
with Clarithromycin (1024 µg/ml) and Trimethoprim/Sulfametoxazole (160 µg/ml 
for P. aeruginosa PAO1 and 640 µg/ml for INT strain respectively) measured by 
CV staining (effect on bioﬁlm biomass) (A) and colony  counting (effect on cell 
viability) (B), compared to a control bioﬁlm (n=3, Average ±SEM; p<0.05). 
  
 
86 
 
Figure 15. Antibiofilm activity of  SeNPs (128 µg/ml) alone and in combination 
with Levofloxacine (16 µg/ml) and Vancomycin (2 µg/ml) measured by CV 
staining  (effect on bioﬁlm biomass) (A) and colony counting (effect on cell 
viability) (B), compared to a control bioﬁlm, as regard S.aureus Mu50 and UR1 
strains (n=3, Average ±SEM; p<0.05). 
 
 
5.4 EVALUATION OF THE ANTIBIOFILM ACTIVITY OF BIOGENIC 
Sm-SeNPs(-) IN COMPLEX “IN VITRO” AND “IN VIVO” MODELS 
Chronic wound model 
The in vitro model used in this study displays specific aspects of wound biofilms, 
mimicking the real conditions in chronic wound and soft tissue infections having a 
surface consisting of hyaluronic acid and collagen  (representing the nutritional 
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conditions present in an infection site). Biofilms were grown on artificial dermis 
(AD) as previously described (Fig.16). We decided to focus our attention on two 
S. aureus strains, the MRSA Mu50 strain (considered as a reference strain) and 
the clinical isolate UR1 as they belonged to a bacterial species recurrent in chronic 
wound and ulcers infections (Wang, 2017). Then we decided to include also P. 
aeruginosa PAO1 strain, as representative of Gram-negative bacteria.  
The biofilm inhibiting and eracating activity of Sm-SeNPs(-) was tested using the 
concentration of 128 µg/ml. Results were reported in Figure 17. For all the strains 
tested and in both inhibiting and eradicating activity the number of bacterial cells 
(CFU/dermis) still present in the biofilms after treatment with NPs were no 
significantly different from the untreated control. Indicating that in this model 
Sm-SeNPs(-) have no effectively antibiofilm activity. Then we decided to 
increase the concentration of NPs used to treat the different biofilms. Also using 
the highest dose of 256 µg/ml of SeNPs, no relevant antibiofilm activity was 
detected for all the strains tested (data not shown). 
 
 
 
 
 
 
 
 
 
Figure 16. AD infected with S. aureus Mu50. Arrows indicate the bacterial 
biofilm formed on the surface of the dermis after 24h of incubation at 37 °C. 
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Figure 17. Biofilm inhibitory effect (A) and biofilm eradicating effect (B) of 128 
µg/ml Sm-SeNPs(-) on P. aeruginosa PAO1, S. aureus Mu50 and S. aureus UR1 
mature biofilms. Results were expressed as log CFU/dermis (mean ± SEM; n=3; 
p< 0.05) and compared to an untreated control. 
 
Biofilms grown on AD were also stained with Live/Dead staining as described in 
“Material and Methods” and directly poured on their surface. After the incubation 
period the AD was overturned and the surface covered by the biofilm observed at 
the fluorescence microscope (Fig. 18). The observation was only possible for the 
S. aureus strains because in the case of P. aeruginosa, during the infection process 
the bacterial cells are able to produce an anticoagulant enzyme able to liquefy the 
dermis. Here, we reported two pictures about the Mu50 strain (Fig.18). The 
treated biofilm appeared different in shape but the cells green fluorescence 
emission suggest that they are still alive after treatment with SeNPs (Fig.18B). 
This data was confirmed by the colony counting (Fig.17). 
A                                                                                                                            B 
                                                                                              
 
 
 
Figure 18. Observation at fluorescence microscope of AD infected by S. aureus 
Mu50 biofilm compared to an infected AD treated with Sm-SeNPs. 
89 
 
 
Trying to hypothesize a possible explanation for this lack of activity of SeNPs, we 
decided to test the antimicrobial activity of Sm-SeNPs(-) against the three strains 
considered using the TSB medium enriched with fresh plasma, one of the 
components of the used to prepare the medium necessary for the infection 
protocol. The MIC values obtained where then compared to the ones previously 
calculated using simple TSB medium. From the results (Tab.14) is evident that a 
medium added with plasma can interfere with the antimicrobial activity of SeNPs 
probably binding to some of the component of the organic layer surrounding the 
surface on NPs. Thus resulting in a 2-4 times increase of the MIC values. From 
the literature we have examples reporting the different activity of metal 
nanoparticles depending on the type and the composition of the medium used, that 
in some cases, could affect the toxicity of NPs (Loza, 2014). 
 
Table 14. Minimum inhibitory concentration values of Sm-SeNPs(-) calculated 
using the tryptone soy broth (TSB) medium enriched with plasma compared to the 
simple medium.   
 Sm-SeNPs(-) MIC µg/ml 
 TSB TSB+Plasma 
P. aeruginosa PAO1  8 32 
S. aureus Mu50 64 >512 
S. aureus UR1 4 256 
 
 
Flow cells 
Due to their complexity, natural microbial communities and biofilms have been 
challenging objects of investigation also because they are often located at places 
that are difficult to access, which makes a direct and continuous examinations 
very difficult (Pamp 2009). To reduce complexity and facilitate investigations 
under controlled and reproducible laboratory conditions, a number of complex 
biofilm model systems have been established, including the flow-cell-grown 
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biofilms, whose setup allow the cultivation of biofilms under continuous 
hydrodynamic conditions. 
Pseudomonas aeruginosa is an opportunistic human pathogen especially adept at 
forming surface-associated biofilms including catheter-associated urinary tract 
infection and ventilator-associated pneumonia (Cole, 2014). To test the 
antibiofilm activity of SeNPs in this complex in vitro model, we decided to focus 
our attention on two strains of  P. aeruginosa: the reference strain PAO1 and the 
multi-drug resistant strain named INT, isolated form an human urine sample. 
Bacterial suspensions were inoculated in the flow-cell-grown model as previously 
described and the biofilm was allowed to grown for 3 days under a continuous 
flow of medium. Then, the biofilm formed inside the flow chamber was treated 
with a continuous flow of 128 µg/ml of Sm-SeNPs(-). At the starting time (Time 
point 0) and during the treatment (at 1, 4 and 24 h) a sample of the effluent was 
collected and the number and the viability of the cells (CFU/ml) released by the 
mature biofilm during the treatment with NPs was evaluated. From our results 
(Fig.19) we can observe that during the 24 hours of treatment a constant number 
of cells was released by the control biofilm. Regarding the 4-old-days biofilms 
treated with SeNPs (Fig.19) there is a release of a lower number of culturable 
cells during the time of the treatment. This result can be probably explained 
considering that NPs are able to kill part of the bacterial cells that compose the 
biofilm.   
After 24 h of treatment with SeNPs the number of cells (CFU/ml) still present in 
the biofilms were determined both by conventional plating on TSA medium and 
microscopy and compared to an untreated control. The chamber used in the flow 
model was formed by two glass slides, the upper one was scratched and used to 
collect the biofilm after treatment with SeNPs, considered the one formed by 
bacterial cells that can actively bind the glass surface. The other glass slide was 
used for microscopy analysis.   
The results in Figure 20 confirmed the data previously reported indicated that the 
treatment of P. aeruginosa biofilms with a continuous flow of Sm-SeNPs(-) 
results in a killing of bacterial cells with a significant reduction in the number of 
colony forming unit.  Is interesting to notice that, regarding the drug-resistant INT 
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strain, in this model the NPs seems to have an higher antibiofilm activity if 
compared to the results obtained in the in vitro microtiter plate assays. This is 
probably due to a different conformation of the biofilm structure formed inside the 
flow chamber compared to the one on the bottom of the microwells. The incessant 
supply of nutrients brought by the fresh medium could lead to the formation of a 
less resistant biofilm matrix, more sensitive to the NPs antimicrobial activity. 
The observation of  P. aeruginosa PAO1 and INT biofilms at fluorescence 
microscope, after Live/Dead staining, highlighted the presence of a large number 
of dead cells (red staining) in biofilms of both strains tested, if compared to the 
untreated control.  
 
 
Figure 19. Antibacterial activity of Sm-SeNPs(-) evaluated by collecting the 
effluent from the flow chamber system during the 24 h of treatment. The number 
of CFU/ml is compared to the one of the time point zero that can be considered as 
a control (mean±SEM, n=3, p<0.05). 
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Figure 20. Antibiofilm activity of Sm-SeNPs(-) measured by CFU/ml counting 
(cell viability). Four days-old P. aeruginosa PAO1 and INT biofilms were treated 
for 24 h with a continuous flow of 128 µg/ml per minute (mean ±SEM, n=3, 
p<0.05). 
 
 
                                                                                                                            
PAO1 
 
 
 
INT 
 
 
 
 
Figure 21. P. aeruginosa PAO1 and INT 4 days old biofilms stained with 
Live/Dead dye. The mature biofilms treated for 24 h with a continuous flow of 
128 µg/ml (B) were compared to a non treated control (A).  
A B 
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As we can see from Figure 21 the structure of the control biofilm and the treated 
one appeared very similar but with a number of live cells (green) apparently 
different. After the treatment with SeNPs most of the cells still present in P. 
aeruginosa PAO1 and INT biofilms seemed to be dead (red staining). This results 
confirmed the ones obtained by counting the CFU/ml  (Fig.20) after removal of 
the biofilms in the flow chambers and  plating on a growth medium.  
 
 
Caenorhabditis elegans  
C. elegans strain N2 ∆glp-4 ∆sek-1 was used. Nematodes were cultured as 
previously described in the “Materials and Methods” section and infected with P. 
aeruginosa PAO1 (Fig.22), S. aureus Mu50 and S. haemolyticus UST1 strains. 
Table 15 shows the percentage of survivor of the nematodes after 24 h after 
treatment with 128 µg/ml of Sm-SeNPs(-). As we can clearly see the percentage 
of survivor is very low (less than 20%) for all the strains considered if compared 
to the non treated control (survivor of 100%). 
After that we decided to treat C. elegans with different concentrations of SeNPs to 
see if the NPs alone had a toxic effects on warms viability (Tab.16).  After 24 h of 
treatment we had only 2% of viability in nematodes challenged with 128 µg/ml, 
which is the lowest concentration having a relevant in vitro antibiofilm activity 
(Fig.22). After 48 h of treatment this percentage is reduced to zero. On the 
contrary, as we can see form Table 16, with lower concentration the viability of C. 
elegans at 24 and 48 h is higher, with a percentage ranging from 90 to 100% at the 
lowest concentration tested (1-8 µg/ml). 
From our results we can conclude that the concentration of 128 µg/ml of Sm-
SeNPs(-) used to treat C. elegans infected with P. aeruginosa PAO1, S. aureus 
Mu50 and S. haemolyticus UST1 was to high resulting in a completely killing of 
the warms due to a possible toxic effect of the SeNPs and not to the infection 
process. The concentration that appeared non toxic for the C. elegans model were 
considered too low to have an antimicrobial or antibiofilm activity. 
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Table 15. Percentage of survivor of C. elegans infected with P. aeruginosa PAO1, 
S. aureus Mu50 and S. haemolyticus UST1, after treatment with 128 µg/ml Sm-
SeNPs (-) for 24 h (n=2; average±SEM)). 
 
P. aeruginosa PAO1 S. aureus Mu50 S. haemolyticus UST1 
2.8±2.7 % 0.4±1.2 % 13.6±2.7 % 
 
Table 16. Percentage of survivor of C. elegans after 24 and 48 h of treatment with 
different concentration of Sm-SeNPs(-) (n=3; average±SEM). 
    
SeNPs µg/ml 
   
TIME 1 2 4 8 16 32 64 128 
24H 100 100±2 100±0.5 92.8±3 100±4.5 98.6±0.5 95.2±3 2.8±13.5 
48H 100 94.1±2.12 92.8±0.3 94.1±2.12 84.6±3.8 84.4±0.3 12.8±2.1 0 
 
                       
                                                               
 
Figure 22. Microscope imagies of C. elegans nematodes uninfected and treated 
with 128 µg/ml of Sm-SeNPs(-) (B), infected with  P. aeruginosa PAO1 (C), 
infected with PAO1 strain and treated for 24 h with 128 µg/ml of SeNPs, 
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compared to an uninfected and untreated control (A). At the end of the assay, 
worms were considered dead if they were straightened and if no movement was 
observed. 
 
 
Mouse model 
A number of 9 WT and 9 CF mice were intra-tracheally challenged with different 
concentrations (50μg/ml, 500 μg/ml and 5 mg/ml) of Sm-SeNPs and monitored 
for the 5 days after the treatment for the onset of toxic effect in term of viability, 
motility and adverse reaction to the administration of NPs. No toxic effect were 
detected in the treated mice compared to a control group intra-tracheally 
challenged with PS.  
 
 
5.5 POSSIBLE TOXIC EFFECTS OF BIOGENIC SELENIUM 
NANOPARTICLES ON HUMAN DENDRITIC CELLS AND 
FIBROBLASTS 
Evaluation of cell viability 
The biogenic SeNPs used in this study contain organic substances of bacterial 
origin, so it was necessary to determine whether they can damage human cells, or 
stimulate unanticipated effects in immune system cells. From the literature we 
have different examples of nanoparticles reposnsible for human cell stimulation 
and cytotoxicity (Di Gioacchino, 2011; Chang, 2010). We therefore investigated 
whether Sm-SeNPs(-) and Bm-SeNPs(+) affected the viability and activity of 
human dendritid cells (DCs), immune system components fundamentally involved 
in the inflammatory and immune response process (Schakel, 2009; Granucci, 
2008). Ch-SeNPs, lacking biogenic molecules, were also tested and compared to 
the biogenic ones.  Human blood monocytes were cultured for 5 days in the 
presence of Granulocyte-Colony Stimulating Factor (GM-CSF) and Interleukin 4 
(IL-4) to obtain DCs, which were then challenged with different doses of SeNPs 
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or with the bacterial immunostimulator LPS, as a positive control. The effect of 
SeNPs on the viability and activity of cultured human fibroblasts was also 
analysed to determine whether SeNPs have adverse effects on non-immune cells. 
Cell viability was assessed using Alamar blue, a colorimetric redox assay of 
metabolic activity. Different concentrations of both biogenic and chemically 
synthesized  SeNPs did not induce apoptosis in cultured DCs or fibroblasts, even 
at the highest dose of 500 µg/ml (atypically high for standard in vitro cell 
stimulation protocols) (Fig.23).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. Evaluation of cell viability. DCs (I) and fibroblasts (II) were treated 
with the indicated concentrations of Sm-SeNPs(-), Bm-SeNPs(+) or Ch-SeNPs for 
24 h, followed by 4 h incubation with Alamar blue. Cells were also incubated with 
100 ng/ml LPS as a positive control. The values are expressed as the percentage 
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of Alamar blue reduction relative to untreated cells (designated as 100%). Data 
are means±SD of four experiments. 
 
Quantification of cytokine production 
We then investigated whether SeNPs stimulate DCs to release of pro-
inflammatory and immunostimulatory cytokines. Particularly we investigated the 
production of those involved in the activation of inflammatory and immune 
responses, such as IL-12, IL-8 IL-6 and tumor necrosis factor alpha (TNF-α). The 
analysis of DC culture supernatants by enzymelinked immunosorbent assay 
(ELISA) revealed that SeNPs did not induce a significant increase in the release 
of IL-12, IL-6, IL-8 or TNF-α until the doses reached 250-500 µg/ml, which are 
unlikely to be achieved in vivo (Fig.24). Cytokine release was stimulated more 
efficiently when DCs were challenged with Sm-SeNPs(-) rather than Bm-
SeNPs(+), but bacterial LPS had a much more potent effect. Interestingly, the 
synthetic SeNPs did not induce the release of cytokines at any dose, suggesting 
that inorganic selenium is unable to stimulate human DCs alone and that the 
organic molecules coating the surface of biogenic SeNPs must be responsible for 
the observed effect. We also explored whether SeNPs influence the release of pro-
inflammatory cytokines by human fibroblasts. We found that neither the biogenic 
SeNPs nor the Ch-SeNPs induced the secretion of IL-8, IL-6 or TNF-a by 
fibroblasts (data not shown), whereas 1 µg/ml as a positive control induced human 
fibroblasts to secrete all three of these cytokines (data not shown). Collectively, 
our results demonstrate that although SeNPs inhibit bacterial growth, they are 
unable to cause significant damage to human DCs and fibroblasts or to stimulate 
the release of cytokines from the same cells. 
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Figure 24. Quantification of cytokine production. DCs were challenged with the 
indicated amounts of Sm-SeNPs(-), Bm-SeNPs(+) or Ch-SeNPs for 24 h. DCs 
were also activated with 100 ng/ml LPS as a positive control. The release of the 
indicated cytokines into the culture supernatants was evaluated by ELISA test. 
The results are expressed as the mean value±SD of three independent 
experiments. Statistical analysis: SeNP-treated DCs versus untreated cells (p < 
0.05). 
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6. DISCUSSION 
 
Antibiotic-resistant infections in the last decades started to be more and more 
widespread, particularly in nosocomial contexts. Emergence of such pathogenic 
conditions can be responsible of longer hospital stays and an increased rate of 
mortality (Ferri, 2015). In such a scenario, major concerns are associated with 
multi-drug resistant (MDR) bacteria and bacterial communities able to grow 
forming biofilms. The widespread drug resistance is further exacerbated by the 
retreat of the pharmaceutical sector from new antibiotic development. These 
challenges highlight the demand for alternative and effective antimicrobial 
strategies. 
Over the last few decades, the application of nanotechnology, particularly the use 
of nanoparticles for drug delivery, has generated significant impact in medicine. 
Several studies have already analysed the antimicrobial activity of different types 
of nanoparticles and specifically of chemically synthesized SeNPs towards 
different pathogenic bacterial strains. Chemically synthesized SeNPs were able to 
inhibit the growth of  Staphylococcus aureus strains, including MRSA clinical 
isolates (Chudobova, 2014; Tran, 2011). Moreover, clinical isolates of P. 
aeruginosa, S. aureus and P. mirabilis, have been show to be particularly sensitive 
to SeNPs biogenically produced by a Bacillus sp. isolate (Shakibaie, 2014).  
In the present study we analyzed, in a large number of bacterial isolates, the 
antimicrobial and antibiofilm activity of biogenic Selenium nanoparticles, 
produced by exploiting the selenite reduction capability of two environmental 
bacterial isolates. We consider the data obtained in this study would represent a 
contribution to investigate the possible use of these nanomaterials as an 
alternative strategy in the treatment of challenging drug resistant diseases. 
 
In the first part of the study, the characteristics of different types of NPs were 
analyzed in order to identify and optimize the parameters associated with the 
highest NP efficiency as antimicrobial agents. 
The physiochemical characterisation of the three types of SeNPs tested in the 
study, revealed that the elemental composition of the biogenic SeNPs was 
very similar. On the contrary, the chemically synthesized NPs showed a 
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different percentage in weight of Carbon, Oxygen, Selenium, Phosphorus and 
Sulphur. The higher content of these organic elements in the SeNPs produced 
by B. mycoides (Bm-SeNPs(+)) and S. maltophilia (Sm-SeNPs(-)),  suggested 
the presence of biological macromolecules surrounding the nanomaterials. 
Both the fact that biogenic NPs showed a bigger size, if compared to the 
chemically synthesized, and the releasing mechanism from the intracellular 
environment hypothesized for NPs production by bacterial cells, give effort to 
this supposition. Indeed, Lampis and collaborators (Lampis, 2016) gave a partial 
description of the organic molecules bind to the Se
0
 core of the NPs produced by 
S. malthophilia SeITE02, suggesting the presence of carbohydrates, lipids and 
proteins, totally absent or present in a smaller quantity in the synthetic 
counterpart. Other authors, investigated and confirmed the presence of functional 
groups typical of proteins and carbohydrates on biogenic SeNPs (BioSeNPs) 
suggesting the existence of extracellular polymeric substances (EPS) on the 
surface of these nanomaterials (Jain, 2014). There is also evidence that the EPS 
are able to govern the surface charge of BioSeNPs as well as contribute to their 
colloidal properties (Jain, 2014) of primary importance in mediating the anti-
microbial activity of metallic NPs in general. 
The cell free extract (CFX) obtained from SeNPs produced by B. mycoides and S. 
maltophilia, containing most of the soluble molecules and organic components 
deriving from the bacterial cells, by itself has not shown a relevant antimicrobial 
activity, as shown by calculating its minimum inhibitory concentration (MIC) 
against the bacterial growth, and comparing it to the MIC values of the native 
biogenic SeNPs and the chemical ones. The evidence that the CFX alone, as well 
as CFX simply added to synthetic SeNPs, showed no activity against the tested 
strain P. aeruginosa PAO1, may suggest that the antimicrobial activity of 
biogenic SeNPs is primary due to the Selenium nanoparticle core surrounded 
by a complex biomolecular cap that is in some way associated to them as a 
result of the biosynthetic mechanism. For that reason, is necessary to emphasize 
again that with the term biogenic Selenium nanoparticle (Bm-SeNPs(+) and Sm-
SeNPs(-) in the text), we refer to a nanomaterial composed by an elemental 
Selenium (Se
0
) core covered by a complex organic cap to date not completely 
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characterized. 
 
The antibacterial activity of biogenic Bm-SeNPs(+) and Sm-SeNPs(-) was tested 
against a series of clinical and reference P. aeruginosa and Candida isolates and 
compared to the one of chemically produced SeNPs (Ch-SeNPs). Interestingly, the 
synthetic NPs, even though they showed a smaller size compared to the biogenic 
ones, seems to be not effective against the bacterial growth, as revealed by the 
very high MIC values recorded. Moreover, the two types of biogenic SeNPs 
showed a slightly different antimicrobial activity, with MIC values generally 
higher for the NPs produced by B. mycoides, suggesting a less efficient 
antimicrobial activity. As a matter of fact, from the literature is evident that the 
size of metallic nanoparticles is a key element in their antibacterial activity 
(Wang, 2017), the smallest they are, the highest antimicrobial activity could be 
detected. Sm-SeNPs(-) produced by S. maltophilia, turned out to be the most 
active, in term of antimicrobial activity, against the strains tested, revealing for 
some isolates (the reference strain PAO1 and the clinical BR2, CFC20, CFC21, 
CFCA, CFCB) low MIC values (ranging from 8 to 16 µg/ml) suggesting the 
possibility of using the biogenic Sm-SeNPs as a tool to avoid bacterial growth.  
Conversely, for other strains tested, the use of Sm-SeNPs(-) seemed not to be an 
efficient antimicrobial treatment, given the very high MIC values (512 µg/ml). In 
this contest, we can only describe the obtained values referring to them in term of 
high or low: is not possible to consider the strains tested as susceptible or resistant 
to NPs, lacking reference values as the standard breakpoints of the commonly 
used antibiotics. 
Generally, it was detected a variable susceptibility among the strains tested that 
seemed to be dependent on the single isolate and not on the bacterial species. This 
observation was subsequently confirmed in a second part of the study for a wide 
range of bacterial isolates belonging to different species, both from Gram-positive 
and Gram-negative bacteria.  As an example, within the species P. aeruginosa, a 
wide range of MIC values, from 8 to 512 µg/ml, was detected among the 12 
strains tested, not being possible to associate the different susceptibility of the 
tested strains to any parameter such as the origin of the strain (ATTC collection or 
102 
 
clinical), the site of isolation or the type of patient involved in the study. Other 
parameters such as the physiological state or the cell surface charge have to be 
analyzed to understand the mechanisms underlying the bacteria susceptibility to 
NPs. 
The investigations on the inhibitory and disaggregating activity of the three types 
of SeNPs on various bacterial biofilms confirmed the deep differences detected on 
the activity of chemical SeNPs compared to the biogenic ones, while a slight 
difference was evidenced between the two types of the NPs of bacterial origin. 
The SeNPs produced by S. maltophilia proved capable of inhibiting the biofilm 
formation also at the lowest concentration tested (50µg/ml) with a different 
antibiofilm activity depending on the strain considered. Indeed, some clinical 
isolates, collected from the sputum of CF patient and low respiratory infection, 
showed to be very susceptible to the NPs activity with percentage of inhibition up 
to 50% at the lowest concentration tested. Moreover, the Sm-SeNPs(-) inhibiting 
activity seemed to be dependent on the concentration. 
Regarding the disaggregating activity on the mature biofilm polysaccharide 
matrix, the Ch-SeNPs confirmed their low  activity, while Sm-SeNPs(-) showed a 
good antibiofilm activity being able to disaggregate the EPS matrix, for more than 
40% already at 100µg/ml, in seven of the nine strains tested (except for BR1 and 
BR2 strains). Interestingly, the antibiofilm activity did not increase significantly at 
higher SeNP concentrations. Similarly, Sm-SeNPs(-) were able to disaggregate 
Candida biofilms of 40-60% already at the lowest concentration tested and no 
improvement at higher doses was detected. Bm-SeNPs(+) resulted slightly less 
efficient in eradicating the mature yeast biofilm than the one produced by S. 
maltophilia and the synthetic NPs had no substantial antibiofilm effect as already 
reported. 
The results regarding the antimicrobial and antibiofilm activity of biogenic 
SeNPs point out a different efficiency potential of the two types of NPs tested. 
In any case they are more active than their chemical counterpart. This, lead 
us to suppose that the different antimicrobial efficiency of nanoparticles 
originating from distinct taxonomically bacterial strains could be due to the 
presence of a different organic coating on the surface of the NP, as a result of 
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the excretion mechanism by the producing bacterial cell. 
 
There is a significant gap in the knowledge of the biogenic SeNPs formation 
mechanism. In particular, it is unclear the way through they achieve the final 
control of the secreted nanoparticle and the composition of the originating 
particle. Several studies underlined the importance of proteins as key factors in 
the growth and final nucleation of metal nanoparticles (Dobias, 2011). For our 
purpose, native (Untreated) Sm-SeNPs(-), obtained as a result of 24 h incubation 
of S. maltophilia SeITE02 in the presence of selenite, were compared to the same 
biogenic nanoparticles undergoing increasingly stronger denaturing procedures 
namely i) denatured through a treatment with 10% SDS; ii) treated with 10% SDS 
and 10 min boiling, and iii) completely denatured with 10% SDS and 30 min 
boiling. By increasing the strength of denaturing treatments, a progressive 
loss of proteins and carbohydrates from the organic coat surrounding Sm-
SeNPs(-) was evidenced along with the increase of nanoparticle size and a 
change in their Z potential. Accordingly to data reported in literature 
(Dobias, 2011), the growth in size of biogenic selenium nanoparticles is a 
consequent effect of the denaturation process. Truly, the increase in NPs size 
is due to a gathering of particles that, deprived form their stabilizing coat, 
tend to aggregate. The partial loss of the external complex organic coating 
followed by an increase in the NPs size underline and confirm its pivotal role 
in preventing particle aggregation. Furthermore, as well known (Hunter, 1981), 
the stability of treated SeNPs is reduced by the shift of Z potential measurements 
toward less negative values: NPs with charges close to a neutral value tend to 
agglomerate. 
The anti-microbial activity of the four different types of SeNPs tested against 
different bacterial pathogens was quantified by MIC value determination. In 
accordance to the previous results, a wide variability of bacterial response to these 
nanoparticles was detected, not only among different species but also within 
strains belonging to the same species. Among the various clinical isolates and 
reference strains tested, belonging to both Gram-positive and Gram-negative 
species, some of them showed low MIC values (4-16 µg/ml) while other 
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evidenced higher MIC values (32-64 µg/ml), suggesting a good antimicrobial 
activity despite the different effectiveness. Equally, are reported in literature 
examples of a different susceptibility to metal NPs depending on the strains tested 
(Piacenza, 2017; Shakibaie, 2014), without an apparent explanation.   
As a general rule, despite the different susceptibility of the various strains, 
the anti-microbial efficacy of native Sm-SeNPs(-) decreased with the 
progressive loss of the organic coating layer. These findings suggested that 
antimicrobial activity of SeNPs is size-dependent, with the highest inhibiting 
effects associated to the smallest particles, which confirms the data already 
reported in previous studies (Zonaro, 2015; Chudobova, 2014; Lu, 2013). 
Indeed, removal of the external organic cap which leads to a progressive 
increase of particle dimensions overlap with a gradual decrease in anti-
bacterial efficacy. 
To verify a direct influence of the organic capping surrounding these nanoparticles 
on their biocidal potential, not only as a particle stabilizing element, SeNPs from 
strain SeITE02 cultures after a 48 h incubation (Sm-SeNPs(48)) were tested for 
their antimicrobial activity and compared to those obtained after 24 h. The SeNPs 
obtained in that process appeared larger in size than those recovered as the 
product of a 24 h growth, but similar in dimension to the ones obtained by means 
of the strongest denaturing procedure (10%SDS+30’boiling) considered in this 
study. Indeed, the NPs size is depending on the age of the cultures (Lampis, 
2014). 
These biogenic Sm-SeNPs(48) owning their native surrounding layer, although as 
large as the ones deprived of the organic coating, showed MIC values 
significantly lower than those detected with fully denatured SeNPs, suggesting a 
role of the organic cap surrounding biogenic SeNPs in the efficacious anti-
microbial interaction with target bacterial planktonic cells and biofilms. 
 
With reference to the induction of loss of biofilm biomass, native Sm-SeNPs(-) 
were able to significantly disaggregate the exopolymeric matrix produced by all 
the bacterial strains tested. Moreover, quantification of culturable cells still 
embedded in bacterial biofilms after treatment confirmed the biocidal potential of 
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native Sm-SeNPs(-), with a marked reduction in colony forming units counting in 
five of the six strains tested, except S. haemolyticus UST1 which instead showed a 
high cell viability after treatment. Results from the tests, carried out with 
partially denatured SeNPs or nanoparticles completely missing the outer 
coating layer, confirmed the key role played by the organic cap even in terms 
of anti-biofilm activity. 
 
Although the mechanisms through which metal/metalloid nanoparticles exert their 
anti-microbial activity are not completely understood and characterized, a number 
of authors addressed the production of reactive oxygen species (ROS) as one of 
the possible mode of action (Manke, 2013; Yan, 2013). In particular, anti-
microbial effects of different selenium compounds have been attributed to the 
formation of free radicals (Tran, 2009). In this study, exposure of three 
bacterial strains P. aeruginosa PAO1, S. aureus Mu50 and B. cenocepacia 
LMG16656, to Sm-SeNPs(-) actually caused an increase in ROS production 
compared to the controls. 
 
Taken together, the results regarding the antimicrobial activity of biogenic SeNPs, 
suggested their possible use as an efficient alternative strategy in the treatment of 
infectious diseases, including those particularly challenging for their resistance to 
different antimicrobial drugs. However, further investigation is needed to 
understand why some strains of a certain bacterial species respond to NPs while 
other strains of the same species appeared resistant to the action of the selenium 
nanomaterial.  
The experiments on the possible synergistic activity of biogenic SeNPs produced 
by S. maltophilia and some selected antibiotics evidenced that, for several of the 
strains tested namely  P. aeruginosa PAO1,  S. aureus Mu50 and S. aureus UR1, 
there is a concomitant action but the biggest part in the disaggregating activity of 
the mature biofilm is due to the Sm-SeNPs(-) potential. The NPs alone 
performed a very strong antibiofilm activity which is slightly increased when 
the nanoparticles are together with the antibiotics. Only in the case of the 
multi-resistant P. aeruginosa INT strain, a relevant biofilm disgregation is 
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detected only using a combination of our nanomaterials and drugs and not 
using SeNPs or antibiotic alone. 
 
The significant  antibiofilm activity of the Sm-SeNPs(-) was confirmed also in the 
complex flow cells model. Due to their complexity, biofilm microbial 
communities have been challenging objects of investigation, also for the fact that 
biofilms are often located at places that are difficult to access and directly 
examine. A number of model systems have been established, including flow-cell-
grown biofilms, that could facilitate these investigations in laboratory conditions 
and in combination with confocal laser scanning microscopy (CLSM) is 
considered the gold standard in biofilm research approach (Pamp, 2009). 
Moreover, such a system could help us in reproducing the conditions of constant 
nutrient supply characteristic of medical devices as urinary and venous catheters 
or heart valves.  In both the P. aeruginosa strains tested, the reference strain 
PAO1 and the multi-resistant INT, the biogenic SeNPs produced by S. 
maltophilia were able to significantly reduce the number of viable cells still 
present in the biofilm matrix inside the flow cell chamber after 24 h of 
continuous treatment. In addition, during the whole treatment, the number 
of viable cells released by the biofilm mass is steadily reduced. 
 
The complete characterization and understanding of biogenic SeNPs production 
mechanism and composition could finally lead us to explain the failure of the NPs 
antimicrobial activity in the chronic wound model and in the in vivo C. elegans 
nematode used in this study. As demonstrated by the obtained results for the 
wound model, is probably that some of the medium components may be able to 
interfere and modulate the interaction of NPs with bacterial cells. A series of 
studies have reported that the environmental conditions can significantly interfere 
with the nanoparticle antimicrobial activity. Temperature, pH, osmotic pressure 
and medium composition  have a relevant role in determining the solubility of the 
NPs and consequently their efficacy (Wang, 2017; Loza, 2014). 
On the contrary, inside the nematodes digestive system the SeNPs may result toxic 
by mechanical obstruction of the gut. Using the same model, Richter and 
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collaborators, (Richter, 2017) reported that quasi-spherical AgNPs of 
approximately 40 nm in diameter were able to successfully increase the survival 
rate of infected nematodes after treatment. X-ray tomography evidenced an 
accumulation of these AgNPs in the worm intestinal tract suggesting that the NPs 
were taken up by the nematodes during feeding. Probably, for the bigger size of 
our Selenium NPs (around 160 nm) and the presence of unknown biomolecular 
compounds on the surface of the particles, a high concentration of them resulted 
toxic. On the contrary, at lower concentrations the Sm-SeNPs(-) did not kill the 
treated worms. 
Nowadays, the NPs antibacterial activity is limited to specific infections scenarios 
and we could only hypothesize their potentiality in clinical settings. 
 
Finally, the evaluation of the SeNPs toxic effect both in the mouse model and 
in human dendritic cells (DCs) and fibrobrasts evidenced that the biogenic 
SeNPs used in this study, as well as those chemically synthesized, are not 
causing cell damage and toxic effects. Different authors reported that 
nanomaterials and metallic NPs in general could be responsible for the induction 
of cytotoxicity and activation of human cell immuno-stimulatory molecules (Di 
Gioacchino, 2011; Chang, 2010). After challenging human DCs and fibroblasts 
with different concentration of SeNPs, neither adverse effect in cell viability nor 
relevant activation of immune-stimulatory cytokines as IL-6, IL-8, IL-12 or TNFα 
was reported, except at the highest concentration of 500 µg/ml tested (which is 
very unlikely to be reached in an in vivo situation). Moreover, the mice treated 
with different concentration of Sm-SeNPs(-), by challenging the NPs intra-
tracheally, did not reveal any adverse respiratory or systemic effect.  
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7. CONCLUSION AND PERSONAL CONSIDERATIONS
 
In conclusion, with the present investigation, we gave evidences that biogenic 
selenium nanoparticles, synthesized by an eco-friendly process, can reasonably be 
considered as reliable antimicrobial and antibiofilm agents able to efficaciously 
inhibit the growth of a number of challenging biofilm-producing bacteria of 
medical interest. Factors that basically are likely to affect the antimicrobial  
potential of the biogenic SeNPs used in this study are the constitutive elements, 
the size and the surface architecture and charge accordingly to the already 
published evidence (Wang, 2017; Zonaro, 2015). In addition to the formation of 
ROS and their relevant role for the biocidal potential, features of the organic coat 
surrounding the biogenic SeNPs show a marked influence on the antimicrobial 
properties of those nanoparticles.  However,  much is still to be clarified in order 
to elucidate the detailed  nature of the external organic coating of biogenic metal 
nanoparticles and their mechanism of action against bacterial cells for an actual 
interpretation of  the intimate biocidal mechanisms. 
The information gained so far on biogenic SeNPs, together with the lack of 
toxicity against the mouse model and human cell lines, open a realistic 
perspective for a possible use of  these nanostructured particles as a novel non-
antibiotic antimicrobial tool to treat fastidious nosocomial infections, included 
biofilm-associated syndromes and  those caused by multidrug-resistant bacteria.  
Regarding the different susceptibility of the tested strains to the SeNPs, this 
remains a major concern. Further investigations are however required to elucidate 
in detail the actual mechanisms of action of these nanoparticles as well to evaluate 
their whole biological compatibility to the human body. 
We must always keep in mind that as happened for antimicrobial drugs, there is 
the concrete possibility of the onset of resistance mechanisms also towards these 
nanomaterials. It is therefore necessary to avoid the indiscriminate use of such 
new alternative strategies and focus on prevention of infectious diseases and 
antibiotics stewardship. 
 
The PhD thesis here presented is, in my opinion, the result of a very good 
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professional collaboration which led to new working contribution between 
different department of the Verona University and different European Universities. 
At the end of my project I can express my own satisfaction about the results 
obtained, moreover, I had the opportunity to travel and attend congresses, courses,  
meetings and collaborate with other students and researchers world renown. 
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